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ABSTRACT 
 
Effects of Ovariectomy and Anatomical Position on the Compact Bone As Seen In Three Month 
Summer Ovine Model 
 
Bryan Kraft 
 
 The purpose of this study is to characterize the compact-bone remodeling response to an 
ovariectomy model of human postmenopausal osteoporosis. Animal models are a beneficial practice 
allowing for the evaluation of the effectiveness of medical therapies and devices on diseases. The ovine 
model was chosen for this study due to its large size, similar bone remodeling to humans, and cost 
effectiveness. The main obstacle to overcome with the use of the ovine model was the lack of natural 
menopause experienced by this species. To overcome this, it was necessary to perform an ovariectomy 
to create estrogen depletion and artificially induce menopause in the sheep. The use of OVX 
(ovariectomized) sheep has been widely accepted as a model for the loss of bone mass. Effects of bone 
loss first appear around 3 months post-ovariectomy, however the effect of the bone loss at the 3 month 
time point as well as its effect on different anatomical positions within the bone have not been 
thoroughly studied. 16 skeletally mature Columbia- Rambouillet cross ewes were used for this portion 
of the study. The group of 16 was divided into 2 groups, one underwent an ovariectomy procedure and 
the other group underwent a sham surgery to put them through the same surgical stress as the test 
group. 3 months post surgery the ewes were sacrificed and had their right and left radii and ulna 
removed. The left radial-ulna bone was then divided into 6 anatomical locations: craniolateral, cranial, 
craniomedial, caudolateral, caudal, and caudomedial. With the bone divided into different anatomical 
sectors, microradiographs were fabricated to allow for further analysis of the bone samples. Using the 
microradiographs histomorphometric measurements were taken to quantify the bone remodeling 
occurring; the measurements taken were the bone volume to tissue volume, fraction of remodeled 
tissue and material, the millimeter (mm) of cement line per square mm of bone tissue and material, 
 v 
Osteons per mm
2
, and the mean osteon area. Densitometry analysis was also performed using the 
microradiographs using image analysis and the use of an aluminum step wedge on each 
microradiograph as a key. Once all of the data was collected a 2-way repeated measures ANOVA 
statistical analysis was performed on the histomorphometry and densitometry data to evaluate the 
possible differences seen due to treatment, anatomical sector, and possible interaction of both. For the 
histomorphometry portion there was a significant variation seen between the caudal sectors of bone in 
the OVX vs control sheep in both the fraction of remodeled material and the mean osteonal area. There 
was also a significant variation seen between the caudomedial sectors of bone in the OVX vs control 
sheep for the average Osteons per mm
2
. For the densitometry analysis it was found that the OVX sheep 
had significantly lower bone density than the control sheep. This study shows that there are significant 
changes seen even after only 3 months with depleted estrogen levels and that differences can be seen 
based on the anatomical sector of the bone. With this information it will be important to take this into 
consideration when creating future studies using the ovariectomized ewe as an animal model for 
postmenopausal osteoporosis study. 
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1. Introduction 
1.1 Purpose 
 More than 75 million people in the United State, Europe, and Japan are affected 
by osteoporosis [1]. Osteoporosis is defined by a decrease in bone mass and alteration to 
bones micro-structure increasing the bone fragility leading to increased risk of bone 
fracture [2]. Estimates suggest that nearly half of women over the age of 50 will break a 
bone due to osteoporosis in their lifetime [3] The National Osteoporosis Foundation 
(NOF) states that the only way to detect  osteoporosis before a bone fracture occurs is by 
the use of a bone density test. The best current known bone density test is duel energy x-
ray absorptiometry (DEXA) [3]. Typical DEXA tests will test the hip, wrist, and spine 
and report results using T-scores. A normal bone density will result in a T-score of -1 
or higher, a test that suggests osteoporosis will result in a T-score of -2.5 or lower [3]. 
Osteoporosis increases the risk of fracture, particularly the spine, wrist, humerus, 
and pelvis. In the year 2000 there was an estimated 5.8 million disability adjusted 
life years (DALY's) attributed to osteoporotic fractures alone [4]. With osteoporosis 
being such a major health threat to such a large population it is necessary to 
understand the mechanisms behind it to better improve our treatments as well as 
how to properly test these treatments with improved animal models.  To reach this 
step the anatomy of bone must be discussed to better understand osteoporosis. 
1.2 Skeletal Biomechanics 
1.2.1 Architecture of Bone 
 Bone is essential to the body, it provides structural support for all other 
components of the body, provides a framework for motion since our muscles need to pull 
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on some rigid body to create motion, offers protection from brunt trauma, acts as a 
calcium repository, and houses the marrow, the tissue that produces blood cells and stem 
cells in the body [5]. The architecture and shape of bones among vertebrate skeletons are 
fairly conservative and stereotypical [6]. With this knowledge it can be seen that at a 
macro level we can usually recognize a femur or a tibia regardless of what animal it came 
from even though there is still quite a varied skeletal morphology amongst vertebrates 
[6]. It would seem that bones amongst a species are somewhat static structures within a 
given species at the macro level [6]. However, once looked at on a scale of microns to 
millimeters, bone becomes a highly dynamic tissue [6].  
 Once we look at bones as dynamic structures we can begin to understand their 
varying shapes and types. Bones are able to sense mechanical loads that are applied to 
them, and are able to modify their structures to adjust to these loads appropriately; this 
principle is known as Wolff's Law [6]. Bone is a very unique material because of its 
ability to have high stiffness in certain directions yet be flexible in others due to its 
material composition and structure [7]. With bone’s ability to be flexible, it is able to 
absorb energy and conform to loads put on it from the environment [7]. 
 Bone is made up of two different types of bone tissue, cortical bone and trabecular 
bone. Cortical bone is the stronger/heavier type of bone with a low porosity, typically less 
than 10% [5]. This bone type is typically found in the shafts of long bone bones and the 
general outer layer of most bones. Cortical bones microarchitecture is essential to 
understanding its mechanical properties. Cortical bone tissue is laid down in layers 5 um 
thick known as lamellae [5]. Within the lamellae collagen fibers run parallel to each 
other, but the orientation of neighboring layers differs, much like many composite 
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materials [5]. The arrangement of lamellae also differs from the outer and inner surfaces 
compared to the space in between. The outer surfaces are circumferentially arranged 
around the bone parallel to one another [5]. The tissue in between the outer and inner 
layers is made up of osteonal bone, which consists of cylindrical structures formed by 
concentric lamellae approximately 200 µm in diameter aligned with the long axis of the 
bone [5]. This solid bone matrix is permeated by an intricate network of canals to provide 
nutrients to the osteocytes trapped in the bone matrix, the central Haversion canals and 
surrounding lamellae make up what is called an osteon seen in Figure 1[6]. 
 
Figure 1 Important features of cortical bone [6] 
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Trabecular bone, also known as cancellous bone, is found in the vertebrae and the 
ends of long bones. Since many age related fractures occur in trabecular bone sites, such 
as the proximal femur, distal radius, and vertebral bodies, it becomes even more 
important to study this type of bone [5]. Trabecular bone is much more porous than 
cortical bone at about 75 – 90% porosity and is made up of a network of interconnecting 
struts called trabeculae [6]. These trabeculae are formed in much the same way as cortical 
bone with lamellae running in parallel to the trabeculae. Trabecular bone’s structure is 
somewhat weaker than cortical bone, however is much lighter due to its much higher 
porosity [5]. Typical trabeculae in healthy bone have an average thickness of 200µm; in 
osteoporosis patients it is seen that there are fewer trabeculae and that they become 
thinner, this will be discussed further later in the paper [5]. 
 With further examination of cortical bone and trabecular bone it can be 
characterized as primary or secondary bone. Primary bone is the bone tissue initially laid 
down on the periosteal surface during growth. Primary bone is typically in the form of 
circumferential lamellar bone, where the lamellae are parallel to the bone surface [6]. 
Blood vessels are incorporated into the lamellar structure surrounded by multiple circular 
lamellae forming the primary osteons and osteonal canals in the bone. The other type of 
bone tissue is secondary bone, which results from the resorption of existing bone and 
replacement with new bone, the process known as remodeling [6]. Most secondary bone 
tissue in cortical bone consist of cylindrical structures known as secondary osteons that 
are about 200um thick much like primary osteons. These new secondary osteons however 
leave a noticeable boundary called a cement line [6]. In adult humans, most compact 
bone and almost all trabecular bone is composed of secondary bone with some remnants 
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of primary osteons that have been only partially resorbed as seen in Figure 2, this is due 
to the continual remodeling and repairing of the bone over one’s lifetime [8]. 
 
Figure 2 Schematic diagram of secondary osteons within an area of primary bone. [6] 
 
1.2.2 Biomechanical Properties of Bone 
 The material that bone is made from is as important to the biomechanics of bone 
as is the shape and structure of bone. Bone like other connective tissues consists of cells 
and organic extracellular matrix of fibers and ground substance produced by cells. 
However, bone is unique because it has a high content of inorganic materials, in the form 
of mineral salts [8]. In normal human bone the inorganic portion consist primarily of 
calcium and phosphate similar to synthetic hydroxapatite. This inorganic material makes 
up 60 to 70% of bones dry weight and is what gives it its rigidity and hardness [8]. Along 
with bone’s inorganic material, its organic material is mainly made up of collagen, 
roughly 90% of all organic material in bone [9], which gives the bone its flexibility and 
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tensile strength [6]. With bones mix of inorganic and organic materials, it obtains unique 
mechanical properties, biomechanically bone tissue can be regarded as a biphasic 
composite material, with the mineral portion as one phase and the collagen and ground 
material as the second phase [8]. Materials such as bone are mainly a strong, brittle 
material with a weaker more flexible material embedded in it to create a combined 
material that is stronger for its weight than either material by itself [8]. Two of bone’s 
most important mechanical properties are its strength and stiffness. These and other 
characteristics can be best understood by examining its behavior under loading. Putting 
different loads on the material will cause it to deform, by measuring these deformations a 
load-deformation curve can be found, much like the example in Figure 3 [8]. 
Figure 3 Example of a Load-deformation curve [8] 
 Information about the bone’s strength, stiffness, and other mechanical properties 
can be found by examining the bone’s load-deformation curve. As seen in the curve the 
first straight portion is the elastic region, where the bone will return to its initial state 
after the load is taken off the bone. Once the load is enough to go past the yield point the 
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material will be permanently deformed to some extent and at a certain load will reach the 
ultimate failure point, at which the bone will fracture. There are three parameters for 
determining the strength of a structure that are reflected on the load-deformation curve: 1, 
the load the structure can sustain before failure (the ultimate failure point); 2, the 
deformation that can be sustained before failure; and 3, the energy than can be stored 
before failure (area under the curve) [8]. The load-deformation curve is a great way for 
determining the mechanical properties of the whole structure, but much like mentioned 
before, the properties of bone change at the micro scale and it is necessary to look at not 
only the mechanical properties of the whole bone, but of the mechanical properties of 
each type of bone and what affects those properties. 
 The biomechanical properties of bone are determined by its composition and 
structure at multiple length scales. On a scale of micrometers the tissue behaves like a 
fiber-reinforced composite with the hydroxyapatite mineral providing stiffness and the 
collagen fibers providing tensile strength and ductility [8]. Once we begin to look at the 
different bone types we begin to see differences in their mechanical properties. When 
looking at an individual trabecular strut it is generally thought to be slightly (20-30%) 
less stiff than cortical bone tissue owing to subtle differences in mineralization and 
lamellar structure [5]. Cortical bone has strongly anisotropic properties, specifically 
stiffness and strength along the bone axis due to the longitudinal alignment of the osteons 
and orientation of the lamellae [5]. Cortical bone is typically loaded along its axis in 
compression, so it lends to the fact that cortical bone is stronger in compression than in 
tension. Bones strength is not only dependent on the strain, but also on the strain rate, 
where the bone becomes stiffer and stronger at higher strain rates [5]. This gives bone a 
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similar characteristic to a viscoelastic material, which is a desirable mechanical property 
to compensate for higher loads imposed by sudden superphysiological loading, such as 
caused by fall impacts or vigorous activity [5].   
 The mechanical properties of trabecular bone have a significant variation in 
stiffness and strength due to these properties being affected by the density and 
architecture of the bone. To test the properties of trabecular bone, a specimen with 
dimensions > 1mm is analyzed for its “apparent” mechanical properties. These properties 
depend on the bone tissue matrix, amount of tissue, and the structural organization of the 
trabeculae which vary with anatomic site, age, and disease [5].  A typical stress-strain 
curve for trabecular bone of different relative densities can be seen in Figure 4 [5]. 
 
Figure 4 Compressive stress-strain curves of trabecular bone of different relative densities [5]. 
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As seen in the figure trabecular bone acts like a linearly elastic material at small strains, 
but then enters a large anelastic region as the trabecular rods and plates collapse under the 
increasing strain. Once the pores within the bone are eliminated by collapsing of the 
trabeculae, the trabeculae begin to run into each other causing a steep rise in the stress. 
With the collapse of the trabeculae, trabecular bone absorbs a high amount of energy 
allowing the bone to undergo large compressive strains without high stress [5]. The 
relative density of trabecular bone strongly affects the mechanical properties of the bone 
which can be seen when the Young's modulus or compressive strength is plotted against 
the apparent density, as shown in Figure 5 [5]. 
Figure 5 Relationship between relative density and Young's modulus (A) or compressive strength 
(B) of trabecular bone [5]. 
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1.2.3 Analysis of Skeletal Biomechanics 
 A more accurate measurement of key material properties of bones is essential to 
better understand the material properties behind bones and to better predict the chances of 
fractures in patients. Several noninvasive bone mass measuring techniques exist and 
mostly depend on the absorption of photons by the bone since the mineral makeup of 
bone is more prone to absorbing photons than the soft tissues, collagen, and water 
contained in the bone [7]. Prior to the 1970's the simplest way to test bone density was 
the use of radiographic films “x-rays”. However, this method used significant radiation 
doses and could have a perceived reduction in bone density of 30-50% due to the 
variability in exposure and processing [7]. In the 1970's a better solution was found, 
called photon absorptiometry, which involves scanning across a bone with a beam of 
photons emitted by a low-level radionuclide and a detector opposite of the beam. This 
method significantly reduced the radiation exposed to the patient and increased the 
accuracy. The system works by being able to record the intensity of the radiation coming 
through the material and knowing the total thickness of the material to produce a curve 
that is proportional to the mineral content of the bone [7]. Later the use of two photon 
beams with different absorption coefficients would correct for the small amounts of 
photons being absorbed by soft tissue giving it even further accuracy. In the 1990's an 
alternate version was implemented that substituted the radionuclide source with a low 
energy x-ray, known as dual energy x-ray absorptiometry (DEXA). This method allows 
for us to be able to scan the whole body for its bone mineral content noninvasively with 
accuracy within 1-2% [7]. The use of microcomputed tomographic scanning (micro-CT) 
has become another accurate method of obtaining three-dimensional measurements of 
bone stereology, volume, and micro architecture in the evaluation of membranous bone; 
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however it is limited to a small section [10]. 
 Another commonly used method for analysis of bone structure and composition is 
stereology. Stereology is a method of exploring a three-dimensional space, when only 
two-dimensional sections through solid bodies are available [7]. This method is often 
used to determine apparent density and calculating porosity.  Stereology uses histological 
cross sections viewed under a microscope and measures the void volume fraction from 
the two-dimensional image. There are a few different methods of measurements used to 
obtain this information. One such method is the use of a “zero-dimensional” technique, 
where a grid of points is placed over the image and the fraction of points that fall on the 
voids is recorded [7]. There have been specific types of grids created of this purpose, one 
such grid that is often used is a Merz grid, seen in Figure 6.  
Figure 6 Merz Grid formed by 36 hash marks on 6 evenly spaced hemicicular lines 
The Merz grid consist of 36 point markings and 6 hemicircular lines, this grid would be 
placed in either the eye piece of the microscope being used or superimposed over an 
enlarged image of the specimen. Using this style of grid the number of points that 
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intersect voids in the cross section of the material in question would be point counted, 
where Pv is the points that intersected the voids and Pt is the total number of points on the 
grid. Using these recorded values a simple ratio for porosity is found (Equation 1). 
Porosity = Pv / Pt             (Eq. 1) 
This ratio can then be used in other calculations to obtain key histomorphometric 
measurements for the bone surfaces. 
1.3 Bone Remodeling  
1.3.1 Remodeling and Resorption 
 As bone grows during childhood into adulthood it needs not only to grow in size 
and length, but be shaped in various ways. The initial increased growth in bone occurs 
when new bone is deposited by osteoblasts without previous bone resorption [11]. 
However, with increasing size the bone needs to maintain its shape and structure 
requiring removal of bone in certain areas and adding it in others. Bone also needs to 
repair itself from fatigue damage and adjust the architecture of the bone as the load 
conditions change over one's lifespan. Bone remodels itself through the coupled removal 
of old bone and its replacement through the synthesis of new bone matrix and its 
subsequent mineralization [12]. Bone does this by involving osteoclastic activity to 
resorb damaged or unnecessary bone and osteoblastic activity to form new bone [7]. For 
the purposes of this paper we will focus on the remodeling actions of bone. Remodeling 
refers to the actions of osteoclast and osteoblasts working in the same site of damaged 
bone, removing old bone and replacing it with new bone [7]. The process of remodeling 
repairs microscopic damage within the bone increasing its mechanical efficiency and 
preventing the accumulation of fatigue damage that could lead to fatigue fractures [7].  
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 This remodeling process is completed by a group of osteoclast and osteoblast 
working together in basic multicellular units, also known as BMU’s. A BMU is made up 
of roughly 10 osteoclast and several hundred osteoblasts [7]. BMU's have a typical 
lifetime that has been broken down into three principle stages: activation, resorption, and 
formation (ARF). The activation occurs when a chemical or mechanical signal causes 
osteoclast to form and begin to remove the specified section of bone. These osteoclasts 
resorb the targeted bone leaving behind a tunnel or trench of approximately 200µm in 
diameter for a varying distance [7]. Osteoblasts then follow at a slower rate, replacing the 
removed bone. The specifics of this process will be discussed in further detail below. 
With the BMU creating a tunnel through the compact bone it creates a new osteon. The 
front end of the BMU contains a capillary “bud” to supply nutrients for the osteoclast and 
osteoblast. Inherently BMU's become isolated within the cortex of the bone and require 
continual vascular supply causing the tunnel to not be completely filled in creating a new 
Haversian canal to allow for the vessels. The osteoblasts that become buried in the bone 
after remodeling are referred to as osteocytes and are interconnected with other 
osteocytes throughout the bone via canaliculi, small tunnels [7].  
1.3.2 Analysis of the ARF Sequence 
 Remodeling is the primary determinant of the mechanical properties of bone, their 
resistance to fatigue failure, and their ability to adapt to changing mechanical 
environments [7]. By understanding the remodeling process we can better understand its 
effects on skeletal tissue mechanics. Once we have this knowledge then we can create 
methods used to quantify bone remodeling and how it actually affects the bone structure. 
 As stated above the remodeling process revolves around the BMU and the process 
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it follows during remodeling. The BMU remodeling sequence follows well defined 
phases that begin with activation, followed by resorption, then finally formation. This is 
known as the A-R-F sequence and can be depicted in the schematic diagram seen in 
Figure 7(fig 3.1[7]) [7]. 
            
 
Figure 7 Schematic diagram of an osteonal BMU. Larger, multinucleated cells to right are 
osteoclast; smaller cells shown in black to left are osteoblast [7] 
 
The A-R-F process can be broken down even further than just activation, resorption, then 
formation, but into 6 phases. 
 First, it starts with activation where differentiated cells must be recruited from 
precursor cell populations before any resorption or bone formation can occur [7]. This 
process typically takes 3 days to produce the osteoclast to begin the origin of the BMU 
[7]. Activation is not completely understood, however there are a few main principles that 
have been the key points of research for what causes the activation of bone remodeling. 
First is that bone may contain sensor cells that monitor mechanical strain. It has been 
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shown that when mechanical stimulus is too low, remodeling removes bone and when the 
stimulus is too high, remodeling adds bone [13]. Second, it has been suggested that 
osteocytes act as bones mechanosensing cells since they are distributed throughout the 
bone matrix. It is also known that osteocytes communicate with each other as well as 
osteoblasts and that they can sense mechanical changes through stretch-activation 
channels, flow of the interstitial fluid, and electrical potentials [14]. Third, is that 
osteocytes may sense fatigue damage and transmit signals activating remodeling to 
remove and repair this damaged bone [13]. The final concept is that cells of osteoblast 
lineage control the initiation of remodeling, many have hypothesized bone lining cells, 
previously osteoblasts, are responsible for activating BMU's to remodel bone in response 
to signals given by osteocytes or hormones [13]. 
 Once the activation phase is completed the newly formed BMU begins the 
resorption phase. Osteoclast move longitudinally at a rate of about 40µm/day in the rough 
shape of a cone with an ellipsoidal surface of approximately 200µm in diameter and 
about 300µm long [7]. This phase goes on for a few days resorbing bone in its path 
before the next phase, called reversal, begins. Reversal is the transition from osteoclastic 
to osteoblastic activity where new bone is formed. The boundary of a completed 
secondary osteon is the cement line also referred to as the reversal line, indicating where 
the transition phase takes place [7]. The total time for the resorption and reversal phases 
takes about 30 days. 
 Once the reversal phase is completed osteoblasts appear around the periphery of 
the tunnel formed by the osteoclasts during the resorption phase and begin refilling the 
cavity, starting the formation phase [7]. Concentric lamellae are laid down by the 
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osteoblasts to fill in the resorbed region. The rate at which the lamellae is placed 
decreases as the refilling progresses averaging at about 1-2 µm/day, this is considerably 
slower than the resorption phase [7].  As it was stated earlier the tunnel is not filled 
completely to allow for a vascular loop to nourish the osteoblasts and osteoclasts during 
the ARF sequence. The tunnel that is left behind, called the Haversian canal, is typically 
40-50µm in diameter. These vessels also aid in transport of calcium and phosphorus to 
and from the bone when necessary [7]. The formation phase in an adult human takes 
about 3 months to complete [7]. 
 Following the formation phase is the mineralization phase. This phase takes place 
after most of the unmineralized organic material has been deposited into the bone matrix 
during the formation phase. There is a delay of about 10 days, known as the 
mineralization lag time, resulting in a layer of osteoid between the osteoblast and the 
mineralization bone [7]. During this phase mineral is deposited within and between the 
collagen fibers found in the new bone. Roughly 60% of the mineralization occurs within 
the first few days, this is known as the primary mineralization. The remaining 40%, 
secondary mineralization, is added at a decreasing rate taking another 6 months to 
complete [7]. This is essential to the understanding of the bones mechanical properties, 
because the properties of incompletely mineralized osteons can vary by large amounts as 
compared to completed (older) osteons. 
 The final phase of the the A-R-F sequence is the quiescene, where the osteoclasts 
disappear from the region, and the trapped osteoblasts become osteocytes or Haversion 
lining cells [7]. The newly formed bone then carries on their usual mechanical, metabolic, 
and homeostatic functions [7].  
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1.3.3 Measurement of Osteonal Remodeling  
 Along with understanding the remodeling sequence of bone it is important to use 
this knowledge to create methods of analysis and measurement of bone remodeling to put 
it into a quantitative form. By having quantitative analysis of how bones remodel, we can 
create more accurate treatments for bone diseases and be able to improve bone healing. 
There already exist multiple methods of analysis currently that are helping us produce 
new and improved treatments. One type of method is using spatial process algebra, the 
shape calculus, using levels of Receptor Activator of Nuclear Factor κ B (RANK) and 
Receptor activator of nuclear factor kappa-B ligand (RANKL) and cellular activity in the 
body in relation to the BMD during bone remodeling [15]. RANK/RANKL signaling is 
an important factor affecting bone metabolism. RANK refers to a protein expressed by 
osteoclasts in bone; RANK is a receptor for RANKL, another protein produced by 
osteoblasts [15]. This signaling triggers osteoclast differentiation, proliferation, and 
activation, prominently affecting the resorption phase during bone remodeling [15]. By 
creating a mathematical comparison of the varying levels of RANKL in one’s system and 
the level of cell activity we can analyze the effects on bone density [15]. This is just one 
example of how a computational approach can be used to analyze bones ability to 
remodel under given conditions. 
 Another method of accurately measuring the amount of bone remodeling in bone 
is the use of diagnostic imaging tools along with computational and biological variables 
to accurately measure bone mass densities and the structures of patient’s bones. The 
adequate conjugation of diagnostic imaging tools, DEXA, along with computational 
numeric simulations may increase the knowledge on bone remodeling and on bone 
strength [16]. Consistent validation methodologies are mandatory to obtain valid results, 
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and furthermore the inclusion of patient-specific information, to express the inter-
individual geometric and biological variability is also valuable in the computational 
model [16]. In one such study the methodology proposed represented a partial validation 
of the bone remodeling model in terms of bone mineral content (BMC) for a specific 
region, namely the femoral neck [16]. In their study DEXA exams were performed on the 
femur of Caucasian women of post-menopausal age and a descriptive statistical study of 
the patients was conducted using their BMD values, age, height, weight, and body mass 
index (BMI) [16]. A computational model was applied to a three-dimensional finite 
element model of the proximal femur for 25 values of k, which can be understood as the 
cost supplied by the human body for bone remodeling depending on age, hormonal 
status, and disease status [16]. Both methods were then compared and it was found that 
there is a set of k values that are able to closely predict the mean formal neck BMC [16]. 
This use of a computational model along with biological variables can accurately predict 
the BMC to that of the gold standard diagnostic imaging tool, DEXA, with small relative 
errors. It also allows for new perspective on osteoporosis by being able to simulate 
multiple variables as compared to DEXA. 
 The measurement of BMC has been done by the use of DEXA or 
histomorphometric analysis with the use of microradiographs of histological sections 
from sacrificed specimens. The option to measure BMC in vivo has been a goal to be able 
to get these measurements without the sacrifice of a specimen to obtain quantitative 
analysis of remodeling bone. Recently it has become possible to use micro-computed 
tomography (mirco-CT) to calculate an objective measurement of the BMC within a 
sample of bone, based on three-dimensional CT scans of excised or live animals [17]. 
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Micro-CT analysis offers the advantage of precise quantification of mineralization within 
a defect, and can be acquired in live animals allowing for serial studies of individual 
animals [17]. The noninvasive micro-CT technique facilitates longitudinal studies and 
provides quantitative estimates of bone growth with high precision (+/-2.5%)[17]. In vivo 
micro-CT data is also acquired at adequate spatial resolution (45m) in a relatively rapid 
time of 15min, making it a very quick and cost effective approach to monitoring bone 
remodeling [17]. 
 With having multiple ways to quantify bone remodeling we can now use this 
information to create new treatments and solutions to bone damage and current bone 
diseases. By creating faster, more accurate and cost effective analysis methods diseases 
can be diagnosed and treatment can be done much earlier and more effectively. 
1.4 Osteoporosis 
 Osteoporosis is the result of reduced bone mass and disruption of the micro-
architecture of bone, causing decreased bone strength and increasing the risk of fracture. 
Bone remodeling plays a critical role in the cause and prevention of osteoporosis. 
Osteoporosis occurs as a result of increased bone breakdown by osteoclasts and 
decreased bone formation by osteoblasts [4]. This creates a negative balance of bone 
formation and the amount of bone resorption. As this imbalance increases it leads to 
excessive bone loss compromising the strength of the bone [11]. An example of the 
effects of this imbalance us shown in Figure 8 below, where the top image is an electron 
micrograph of a 31 year old woman’s vertebra and the bottom image is of a 70 year old 
woman's vertebra. It can be seen that the larger plate like struts have become fewer and 
much smaller rod like struts connecting the overall bone structure creating a much more 
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porous micro architecture as compared to the 31 year old’s bone. 
Figure 8 The structure of L3 vertebra in a 31 year old woman (top) and 70 year old woman 
(bottom) is shown using scanning electron micrographs. Note that many of the plate-like 
structures have become converted to thin rods [4] 
 
 Aging is closely related with bone loss, especially after the age of 50 [4]. With 
increasing age and bone loss, individuals are more prone to bone fractures of the spine, 
hip, wrist, humerus, and pelvis. It has been shown that BMD falls significantly due to 
age-related and menopause-related bone loss [18]. The role of estrogen deficiency in 
menopausal and age related bone loss in women has been well documented [4]. 
Osteoporosis is seen in 10.6% of women with menopause of a duration of 0-3 years, 
16.2% of women with menopause of duration of 3-7 years, 31.9% of women with 
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menopause duration of more than 7 years, and a staggering 70% of women over the age 
of 80 years old [19, 20]. Bone loss also affects men, however the peak bone mass of men 
is 20 to 30 percent higher than woman’s peak bone mass [18]. Along with menopausal 
and age-related bone loss women are much more susceptible to osteoporosis than men. 
There are other key factors that may play roles in developing osteoporosis including 
calcium deficiency, alcoholism, smoking, vitamin D insufficiency, and reduced physical 
activity with aging [4,18]. Genetic factors also are believed to influence peak bone mass 
obtained by the third decade of life. Peak bone mass has been shown to significantly 
affect ones bone mass later in life and is strongly influenced by nutritional intakes and 
level of physical activity [4].  
1.4.1 Postmenopausal Osteoporosis 
 Menopause occurs in woman between the ages of 40-60 where ovarian function 
declines and production of hormones for the body’s endocrine system decreases. In 
particular estrogen and progesterone are produced in significantly lower amounts post-
menopause. Decreasing estrogen levels have shown to play a key role in increased bone 
loss early in the postmenopausal period contributing to an increase risk of fracture 
incidence [21]. There are many different risk factors for the development of osteoporosis 
as discussed earlier, however estrogen depletion has a direct effect on increased bone loss 
and is a major factor in leading to osteoporosis in women. 
 Estrogen has been linked to osteoclast activities in bone remodeling [22]. 
Estrogen’s role in regulating bone loss is connected to the regulation of cytokines that are 
critical to osteoclast stimulation. Interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor 
necrosis factor (TNF) are the cytokines regulated by estrogen [22]. These cytokines are 
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integral in increases in osteoclastogenesis, the osteoclast life span, and also have the 
ability to stimulate their own synthesis. Estrogen’s role in regulation of cytokines: IL-1, 
IL-6, and TNF production can be seen in Figure 9 [22]. 
Figure 9 Regulation of IL-1, IL-6, and TNF production. Each arrow indicates a  
stimulatory effect of a cytokine on its own synthesis, or the synthesis of another cytokine. 
Demonstrated suppression of the stimulated synthesis of IL-6 and TNF by estrogen (“E”) 
is indicated by filled octagons, and the potential suppression of IL-6 induced IL-6 by 
estrogen is indicated by an open octagon [22] 
 
 With an estrogen deficient environment, IL-6 mediates an increase in osteoclast 
formation. When estrogen is present it suppresses IL-6, decreasing the amount of 
osteoclasts being formed [22]. Other cytokines such as transforming growth factor-() 
(TGF-) inhibits osteoclastogenesis by stimulating osteoclast apoptosis. Estrogen 
stimulates TGF- located in osteoblastic cells. With the depletion of estrogen in 
postmenopausal women it is likely that the levels of TGF- are decreased while the levels 
of IL-1, IL-6, and TNF will likely increase. This shift in cytokine levels leads to 
increased lifespans of osteoclasts [22]. With osteoclast lifespans being increased the level 
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of bone resorption is also increased causing a greater amount of bone loss as compared to 
normal conditions [11,22].  
1.4.2 Treatment Option for Osteoporosis 
 Treatments of osteoporosis currently focus on preventing or delaying the onset of 
osteoporosis by increasing ones peak bone mass and by trying to prevent/slow bone loss 
caused by aging and menopause. One treatment procedure is through the use of 
nutritional supplements such as calcium and vitamin D. Calcium and vitamin D are given 
along with other drugs for osteoporosis to those with low calcium intake and elderly 
woman to decrease the rate of bone loss [23]. The use of an annual injection of calcium 
and vitamin D in elderly men and woman has shown trends for reducing non-vertebral 
fractures by as much as 24%. However, the overall efficacy of using calcium and vitamin 
D supplements as a treatment for healthy elderly people with sufficient dairy intake and 
normal BMD has not been established [23]. 
 With menopause and hormone depletion being related with bone loss later in life, 
hormone replacement therapy (HRT) is another possible treatment to help prevent bone 
loss. HRT however is a less sought after treatment due to the associated adverse effects. 
With the decision of using HRT some of the adverse effects taken into account are the 
unknown risk of increased chance of breast cancer, menstrual bleeding, and other 
possible gynecologic symptoms [23]. HRT has shown to reduce markers of bone 
resorption, decrease the rate of bone loss, and decrease incidence of fractures in post-
menopausal and osteoporotic women [24]. Several studies have shown that the use of 
HRT decreases the risk of hip fractures by 30% and a 50% reduction in the risk of spinal 
fractures [23]. The use of calcium supplements along with HRT is hypothesized to further 
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improve bone loss reduction and help reduce fracture risk [23]. Once HRT is withdrawn 
the reduction of fracture risk is lost within 5 years causing an issue of how to optimally 
time and at what duration to give the treatment [23]. Although HRT has proven to be a 
viable option of treatment to prevent increased bone loss, the perception of increased risk 
of breast cancer and other side effects has minimized its adoption as a treatment by the 
majority of the affected population [24]. 
 Another treatment option is the use of bisphosphonates because of their strong 
affinity for bone apatite, being a potent inhibitors of bone resorption by reducing the 
recruitment and activity of osteoclasts, and the ability to be artificially synthesized with 
relative ease [23]. Studies have shown an increase in bone wall thickness in humans and 
nonhuman primates after long term treatment with bisphosphonates, which may indicate 
not only a decrease in osteoclast activity but an increase in osteoblast activity [25]. 
Bisphosphonates have also been used in conjecture with other bone loss prevention 
treatments. One such study compared the use of bisphosphonates, HRT, and the 
combination of the two on their ability to prevent bone loss [24]. The use of a 
bisphosphonate called etidronate with and without HRT was observed over a 4 year 
study. Figure 10 diagrams the results of this study showing that the BMD of the spine 
increased by 6.8% with the use of etidronate, 6.8% with the use of HRT, and by 10.9% 
when etidronate and HRT were combined as treatment [24]. This suggests that the 
combination of multiple treatments that affect the activity of osteoclasts may be the most 
optimal form of treatment. 
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Figure 10 Lumbar spinal bone mineral density (BMD) increased similarly in estrogen and 
etidronate treated patients and by a greater amount using both. EHDP=etidronate; HRT=hormone 
replacement therapy [24] 
 
1.5 Animal Models 
 The US Food and Drug Administration (FDA) have set safety and efficacy 
requirements that must be met before any device or pharmaceutical can be used in human 
treatments. To meet these standards extensive bench and animal testing (also referred to 
as in vivo) are performed. Bench and in vivo testing is used to display general proof of 
concept of the suggested treatment. Animal tests are the next important step in the 
process to be able to test potential therapies in a very complex living system. Animal tests 
also provide us a better means to understand how specific diseases actually affect and 
progress in a living system. Animal studies will typically begin with the use of small 
animals such as mice and rats to mitigate possible risk, allow for larger samples, and 
minimize the time and cost of the initial test. As a therapy proves to be safe and effective 
in smaller animal tests, the next step is moving onto animal testing with animals that are 
more physiologically relevant to humans for the proposed treatment, which tend to be 
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larger mammals. Although certain animal models can be very physiologically similar to 
humans, the need for more accurate simulations of human nutritional needs, lifestyle, and 
physical activity are required to fully meet FDA approval. This is the point in the testing 
process at which human clinical trials begin. 
 In the case of using animal models for treatments of osteoporosis, the animal 
models being involved must simulate osteoporotic conditions in order to test possible 
drug treatments [26]. The need for large animal models with some characteristics of 
human osteoporosis is especially necessary in the design of prosthetic devices with 
different coatings to promote osseointegration. These types of devices must be able to 
perform and not loosen with decreased bone mass. The use of smaller animals is 
impossible when testing human sized devices [26]. 
 There are many different animals that are used for osteoporotic studies due to 
their varying advantages and disadvantages to the given study. Rodents, notably rats, are 
one of the most commonly used animals in osteoporotic studies because of the many 
advantages they offer. In general they are relatively inexpensive, easy to house, and are 
generally associated with research in the public eye. Rats also have a fairly short life span 
facilitating studies of the effects of aging on bone. With many studies utilizing rats, much 
is known about their diets effect on bone aging as well as their bone turnover [27]. It has 
been well documented that rat and mice models have shown cortical thinning and 
increased fragility of bone due to aging. Rat models, however, do not naturally go 
through menopause so ovariectomies are preformed to induce menopause. The rat models 
with artificially induced menopause effectively express similar characteristics to human 
postmenopausal osteoporosis making them useful in studies of the effects of 
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bisphosphonates on bone with estrogen deficient models [28,29]. The induced menopause 
rat models do, however, have a disadvantage in studying the effects of postmenopausal 
conditions on cortical bone because the development of Haversian canal systems and 
impairment of osteoblast function requires 3 to 4 months [29]. 
 Another animal model commonly used in studies involving bone is the rabbit 
model. Rabbits are more commonly used in studies involving bone in growth into 
implants and bone implant interfaces. Very rarely are rabbit models used as an 
ovariectomized model to study the effects of ovarian insufficiency on bone mass [27]. 
The use of a rabbit model for implant models is due to rabbits undergoing Haversian 
remodeling, having rapid bone turnover, and showing skeletal maturity at 7 to 8 months. 
However, rabbits are not fully characterized for osteoporosis. Studies using a rabbit 
model were only able to assess BMD and not able to assess the microarchitecture and 
bone mechanics completely causing it to be a poor model for osteoporosis studies [30].  
 Dogs have been a well-used model for bone studies due to their extensive BMU 
remodeling and larger size. Dogs also have the advantage of being monogastric like 
humans and relatively easy to work with. A major difference in the physiology of dogs 
and humans is that dogs are diestrus, with ovulation only occurring twice a year, where 
humans are polyestrous and ovulate multiple times a year. This becomes a clear 
disadvantage for studies involving estrogen deficiency on bone. It has been shown that 
even with the removal of both ovaries and uteri it does not sufficiently create a significant 
bone loss [27].  The use of dogs in the study of postmenopausal osteoporosis is limited 
due to the lack of sizable response in histomorphometric, bone mass, and biochemical 
parameters [29]. 
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 An obvious choice of animal model to compare to humans is the use of nonhuman 
primates. They offer many advantages dues to their close physiological similarities 
including: the gastrointestinal tract, endocrine system, and bone metabolism. The two 
most documented species used for studies are baboons and macaques monkeys. Female 
macaque monkeys have a similar polyestrous cycle and hormonal patterns to humans. 
With an ovariectomy macaques show significant reduction in cancellous volume [29]. 
One major drawback is the need for the female primate to be significantly aged to act as a 
sufficient postmenopausal model. Other disadvantages to using primates in an animal 
study for osteoporosis are the high cost and difficulties of handling the animals [29].  
1.5.1 Proposed Animal Model 
One of the most promising animal models for osteoporosis studies is the use of 
skeletally mature sheep, especially the use of ewes. Sheep offer many advantages such as 
being of a larger size allowing for device implantation and analysis. They also offer the 
benefit of being easy to handle and being available in larger numbers aiding in the 
performance of large scale studies [31].  Sheep also offer very similar metabolic rates to 
humans compared to other animal models. A study showed that the metabolic rate, based 
on oxygen consumption per gram of body weight, in humans was .21 and sheep’s 
metabolic rate was closest at .22 compared with that of rats (.87) and dogs (.33) [32]. 
Sheep also temporally and quantitatively show a similar hormone profile to those of 
human women [32]. Another advantage of using a sheep model is that young sheep have 
shown to develop plexiform bone, a combination of woven and lamellar bone.  Roughly 3 
to 4 months after development of plexiform bone, Haversian remodeling can be seen in 
the cortical bone (Figure 11) [33]. 
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Figure 11 (A) Plexiform bone from a three-year-old ewe (original magnification x 25). (B) 
Haversian remodeling from the caudal femoral cortex of an eight-year-old ewe (original 
magnification x 25) [33] 
 There are, however, a few disadvantages to using a sheep model. Ewes do have a 
similar reproductive cycle to that of female humans, but they do not show a clear state of 
menopause at midlife. For this reason ewes will not be able to develop postmenopausal 
osteoporosis without artificially inducing menopause via ovariectomy. Ewes also go 
through an annual anestrous period of 1 to 2 months unlike female humans [32]. Another 
disadvantage of using a sheep model is their physiologically different gastrointestinal 
systems. In order to administer drugs orally, surgical insertion is required to bypass the 
microflora of the rumen, a gastrointestinal organ not found in humans [29]. 
 Sheep that have had ovariectomies performed have been used in multiple studies 
of BMD loss previously. When using the ewe as the animal for a study on 
postmenopausal osteoporosis two major factors must be considered, the age of the animal 
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and the season of analysis. Older ewes have shown to be better specimens for this 
purpose. Research has shown that when comparing biopsies of ewes 3 months apart that 
there were decreases in resorption surfaces, osteoblast surface, and bone formation rates. 
This supports the claim that remodeling changes can occur within a 3 month period of 
time post ovariectomy [34]. Changes in bone mass have also been demonstrated in 3 to 4 
year old ewes at the six month mark post ovariectomy (Figure 12) [34]. Other studies on 
osteoporosis using sheep models have shown that significant mechanical changes of the 
spine and ilium did not appear until 12 to 24 month post ovariectomy [35]. 
 
Figure 12 (Left) Three-dimensional reconstruction of a sheep vertebral body biopsy from the 
control group (Right) Three-dimensional reconstruction of a sheep vertebral body biopsy after 6 
months of osteoporosis induction with ovariectomy, steroid application and a calcium/vitamin D-
restricted diet [36] 
 
 Seasonal variation in BMD has been shown in sheep during the winter months. 
Humans have also been shown to have an alteration in BMD due to seasonal variation, 
with BMD levels being lower in the winter as well. This is thought to be caused by 
environmental and nutritional variation. Sheep’s nutrition directly influences their bone 
metabolism, in particular the amount of calcium and vitamin D intake. Vitamin D is 
produced in the skin of animals from the exposure to ultraviolet (UV) radiation. It is then 
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important to consider the amount of time the animals are exposed to light and the daytime 
length during each season of the year [31]. 
 The sheep model has shown to be an overall adequate model for postmenopausal 
osteoporosis once ovariectomized. The model will allow for testing of therapeutic agents 
and prosthetic devices in a very similar atmosphere as in humans. The effects of 
seasonality still need to be further characterized to understand their possible effects on the 
study. Through the following research, a quantifiable model for bone remodeling in an 
ovariectomized animal with further characterization of seasonal and anatomical 
variations will be made through comparison with control animals. 
1.6 Study Objectives 
 The purpose of the current research project is to record empirical data concerning 
the histomorphometry and densitometry of a section of sheep bone samples to further 
understand the effects of estrogen depletion on compact bone secondary remodeling. The 
amount of remodeling will be assessed using the following measurements and 
calculations: the ratio of bone volume to tissue volume, the fraction of tissue remodeled, 
the fraction of material remodeled, cement line interfaces as a function of tissue volume, 
cement line interfaces as a function of material volume, osteons per mm
2
, mean osteon 
area, and bone mineral density. The section of sheep the research for the project will be 
performed for contains the 3 month summer control sheep and OVX sheep taking 
measurements form the cortical bone of the radial-ulna of the ovine's left leg. Analysis 
will be made for variations in anatomical location and treatment. 
 Previous research has shown that sheep do in fact undergo seasonal variations in 
bone properties [31]. The research on comparing the effects of anatomical location on 
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remodeling parameters has been minimal and it is expected that both seasonality and 
anatomical location will have significant effects on remodeling parameters. In this 
portion of the study only 3 month summer sheep were used, so no analysis was taken to 
see the effects of seasonality.  In this study comparisons of anatomical variation and 
possible variations between OVX sheep and the control sham operated sheep will be 
assessed for variations in remodeling parameters due to treatment. This research will 
further show that relevant data about postmenopausal osteoporosis will be obtained from 
the use of a sheep animal model. 
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2.  Materials and Methods 
2.1 Animal Maintenance and Preparation 
 112 skeletally mature Columbia-Rambouillet cross ewes, 5 years or older, were 
acquired and kept at Colorado State University, Fort Collins, Colorado as part of a larger 
experiment. The acquisition and housing of the animals was performed under the 
approval of the Animal Care and Use Committee. The animals were kept at 1500 m 
altitude in dry lots at 41deg north for the duration of the experiment. The animal’s diet 
consisted of a grass-alfalfa hay mixture. The 112 ewes were separated into four groups of 
28 to account for each varying season: autumn, winter, spring, and summer. Once in 
seasonal groups the group was further divided into two groups containing 14 ewes. The 
animals were then taken to the large animal surgery facilities at the College of Veterinary 
Medicine and Biomedical Sciences at Colorado State University, where they were 
anesthetized to undergo surgery. Surgeries took place during the specified group’s season. 
The autumn, winter, spring, and summer surgeries took place in November, February, 
May, and August respectively. Two types of surgery where performed for the varying 
groups. One group of 14 from each seasonal group underwent an ovariectomy (OVX) in 
which the ovaries were identified and removed. The other remaining group of 14 ewes 
from each seasonal group would act as the control group for the experiment and 
underwent a sham surgery in which the ovaries were identified, handled, and not removed 
to make sure both OVX and control groups went under as similar stress as possible. Once 
the surgeries were complete the groups of 14 were again divided into two more groups of 
7. One group would be sacrificed at the 3 month mark after surgery and the other group 
would be sacrificed at the 12 month mark after surgery. One of the 12 month autumn 
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sham sheep died prematurely and thus was included in the 3 month autumn data as part of 
another experiment. The 3 month OVX animals and 3 month control animals for the 
summer season were the experimental subjects for this study. 
2.2 Specimen Preparation 
 Once the animal has been sacrificed the specimen’s right and left radial-ulna were 
removed. The bones were then wrapped in a saline-saturated paper towel then sealed in 
plastic bags and kept at a temperature of -20(deg)C. The bone samples were then 
transported to the Henry Ford Hospital. Once delivered the samples underwent 
preparation for analysis. The center 50 mm of the diaphysis was removed from each 
sample using a ban saw (Model 5212, Hobart Corporation, Troy, OH). The section of the 
radius-ulna was then divided into six anatomical sectors using the Exakt cutting-grinding 
system (Exakt Corporation, Oklahoma City, OK). The six sectors were based on the 
orientation of the bone: cranial, caudal, craniolateral, craniomedial, caudomedial, and 
caudolateral (Figure 13). 
 
Figure 13 Approximate anatomy of the radial-ulnar sectors divided into six sections as indicated 
by the grey lines. The top right is the cranial aspect and the top left is the lateral aspect [37] 
 
 Longitudinal cortical beams were taken from each sector with dimensions of 1.75 
x 1.75 x 19mm. In another study the cortical beams from the left radial-ulna were used in 
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dynamic mechanical testing. 150 m sections were cut from the center of the left radial-
ulna beams and the remaining distal ends were used for drying and ashing to provide a 
method to determine the samples densities. The proximal sections were frozen for 
analysis to be performed at a later time. 
 The 150 m sections were ground down by hand to a final thickness of 100 m 
using fine grit sand paper to prepare the samples to create microradiographs. 
Microradiographs were taken of each section using a 2506AGHD 2.5x2.5x0.06 High 
Definition Photo Emulsion Plates and a HP Cabinet Faxitron (HTA Enterprises, 
Microtome Technology Product, San Jose, CA). The images were done at 25kV for 20 
minutes at 3mA. Each microradiograph consisted of the six sections of the radial-ulna of 
two sheep on both sides and an aluminum step wedge made with increasing layers of 
Reynolds Aluminum Foil in the middle (Figure 14). Aluminum foil was used as a step 
wedge to compare densities because it has a similar atomic number to the effective 
atomic number of hydroxyapatite [38]. The step wedge was created by taping increasing 
layers of aluminum together in a stair step pattern to create increasing levels of aluminum 
thicknesses in a sequential order. Each step in the step wedge is a known thickness and 
can be used to compare the light intensities of each step of aluminum to that of the bone 
samples image to create a method to measure the density of the bone sample as compared 
to the aluminum. 
 36 
 
Figure 14 Diagram of microradiograph layout 
2.3 Microradiograph Analysis 
 The microradiographs were sent from the Henry Ford Hospital to California 
Polytechnic State University, San Luis Obispo for analysis by students in the biomedical 
engineering program. The analysis conducted included histomorphometric measurements 
and densitometry measurements of the bone samples. The histomorphometric 
measurements were taken to obtain a quantifiable amount of remodeling occurring in the 
ovine models. These measurements included: porosity, number of secondary osteons, 
number of cement line interfaces, and the amount of remodeled bone. Densitometry 
measurements were taken to quantify the density of the bone specimens. To obtain these 
measurements the microradiographs were observed using an Olympus BX41 microscope 
(Olympus Optical Co., Ltd, Center Valley, PA) under white light at an objective of 10X. 
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2.4 Histomorphometry 
 Techniques from R.R. Recker’s Text, Histomorphometry: Techniques and 
Interpretation were used for performing the research. [39] For this project there had 
already been some histomorphometry measurements taken for some of the samples. This 
gave a general template to follow while collecting data. This template helped organize the 
findings and gave something to have a loose comparison to. For the current project, a 
Merz grid, seen in Figure 5 previously, was used in the eyepiece of the microscope to 
perform the histomorphometric measurements on the 8 control and 8 OVX sheep sections 
used in this portion of the study. Next the stage of the microscope was modified to hold 
the radiographs. A slide holder was created from a sheet of acrylic by cutting it to the 
proper dimensions to hold the radiographs level on the microscope stage. Once the holder 
was finished the slides were checked to make sure they fit properly and that the holder 
did not interfere with the viewing.  
 Measurements were taken in four regions (named Northwest, Northeast, 
Southwest, and Southeast) for each bone sample and averaged for increased accuracy. To 
begin the Merz grid was oriented in the northwestern corner of the bone sample (Figure 
15). 
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Figure 15 The white box represents northwestern corner then if you were to move the box to the 
right to the edge of the visible bone sample that would be considered the northeastern section. If 
the box is moved to the bottom right corner that would be considered the southeastern section and 
if placed in the lower left would be considered the southwestern region. 
 
 
Once the slide was focused the Merz grid was used to count the number of pores 
(called porosity or void space) that intersected with the dashes on the Merz grid (Figure 
5). Porosity was considered any space which was visibly “black” (porous) which would 
typically occur from Haversian canals, Volkman's canals, or remodeling cavities on the 
slide (Figure 16). 
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Figure 16 White arrows point to areas considered “Porous” 
 The data would then be recorded. To quantify the amount of remodeled bone the 
dashes on the Merz grid that intersected with the “new remodeled bone” were counted 
with a hand tally counter. Once counted the data was recorded in the corresponding table. 
New remodeled bone would be any area of bone within the area contained by a cement 
line interface (an area that clearly had a new cement line around an osteon) (Figure 17). 
 
Figure 17 White arrows point to the cement line interface (the area where the color changes) 
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  The next step was to point count the number of osteons (primary and secondary) 
per field. This was done by counting the osteons within the Merz grid only and record the 
number found. Secondary osteons were characterized by their prominent features which 
include their circular nature, centering on a Haversion canal, the circular patterns by 
osteocyte lacunae, and surrounding cement line. To minimize repeat counts, osteons 
along the upper and right border of the grid would be counted and osteons along the 
lower and left border would not be counted.  The last histomorphic measurement to be 
taken was the cement line interfaces. This was obtained by counting the number of times 
the Merz grid’s “waves” (Figure 5) would cross a cement line interface. Once these four 
measurements were completed and recorded the Merz grid would be moved to be 
oriented in the northeast corner and the above steps would be repeated. The grid would 
then be moved to the southeast section and finally to the southwest corner repeating the 
steps again. Once all of the point counting was completed for a section of bone the data 
would be recorded into an excel chart. It should also be noted that some bone samples 
were damaged or missing, these areas were omitted from taking data as there was not a 
significant amount of bone to take measurements from. The averages and standard 
deviations were calculated using excel for the four different locations for each specimen. 
The previous methods would then be repeated for all of the 3 month summer slides and 
all the data would be recorded in the excel sheet 3moSummer-RAWdata. Once all the 
data was collected the averages of the previously calculated averages for the four regions 
per specimen were calculated for each OVX (ovariectomy sheep) and control sheep to 
see if there was any visible correlation between them.  
Once all of the raw data was collected it was then used to compute the bone 
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volume fraction (BV/TV), fraction of tissue remodeled, fraction of material remodeled, 
osteons per mm
2
, osteons per mm
2 
of material, osteons per mm
2
 of remodeled material, 
mean osteon area, the cement line interface for tissue, the cement line interface of 
material, and the cement line interface of remodeled material, this data was recorded in 
an excel spreadsheet. These were calculated with the equations below (equations 
2,3,4,5,6,7,8,9) . In the equations used the 36 refers to the number of intersection points 
on the Merz grid. 
BV/TV = (1-(Porosities)/36))            (Eq. 2) 
Fraction of Tissue Remodeled = (Remodel/36)          (Eq. 3) 
 
Fraction of Material Remodeled = (Remodel)/ (36-Porosities)        (Eq. 4) 
 
Osteons per mm
2
 (1/mm
2
) = (Osteons/x
2
)                                                                                     (Eq. 5) 
 
Osteons per mm
2
 (Material)(1/mm
2
) = (Osteons/x
2
)/(Eq. 2)          (Eq. 6) 
 
Osteons per mm
2
 (Remodeled Material) (1/mm
2
) = (Osteons/x
2
)/(Eq. 4)       (Eq. 7) 
 
Mean Osteonal Area (μm^2) = 1/((Eq.7)((x)*10
6
)         (Eq. 8) 
 
CLI/mm
2 
of Tissue = ((# of CLI)(4.752))/(6*x)          (Eq. 7) 
 
CLI/mm
2 
of Material = (((#of CLI)/( Eq.2))(4.752))/(6*x)         (Eq. 8) 
CLI/mm
2 
of Remodeled Material = (Eq.3)/(Eq.8)              (Eq.9) 
 
 To further explain the reasons behind using the above equations first the BV/TV 
equation indicates the amount of porosity in the sample by dividing the recorded porosity 
of the sample by the max amount of porosity (36, the number of dashes on the Merz grid) 
and subtracting that value from one. This then gives us a ratio of porosity compared to 
the amount of bone observed. The next two equations represent the amount of tissue that 
was remodeled (fraction of tissue remodeled) by dividing the number of remodeled bone 
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observed in the section by 36 to find the fraction of remodeled tissue. The amount of 
bone remodeled (fraction of material remodeled) was the observed remodeled bone 
divided by 36 minus the observed porosities to obtain only the fraction of remodeled 
bone. The Osteon/ Field equation indicates amount of osteons found within the field. 
Field is defined by the visible area (mm
2
) within the Merz grid used in the optics of the 
microscope. Specifically x in equation 5 represents the length of the sides of the Merz 
grid seen at 10X magnification. The Merz grid used had a dimension of 1mm x 1mm at 
10X magnification, found using a micrometer. X then equaled 1mm in this study. The 
Osteon/Field (Material) equation explains the density of osteons in material as compared 
to tissue, where if BV/TV =1.00, then Material = Tissue. If BV/TV < 1, then the osteonal 
density per area of material is higher than is the osteonal density per area of tissue. The 
Osteon/Field (Remodeled Material) explains the density of osteons in remodeled material 
as compared to material in the same way as Osteon/Field (Material) using the Fraction of 
Remodeled Material instead of BV/TV. The Equation for Mean Osteonal Area is 
calculated by taking 1 over the amount of Osteons/mm
2
 (Eq. 7) multiplied by 10
6
 to 
convert to microns. This gives the Mean Area of an osteon in the observed field. The 
equations for CLI/mm
2
 were found using the CLI recorded multipled by ((4.752)/(6x), 
found by using equations in R.R. Recker’s Text, Histomorphometry: Techniques and 
Interpretation for the Merz grid [39]. 
2.5 Densitometry  
For the next portion of research pictures were taken of the slides under the 
Olympus BX41 polarizing light microscope using a Retiga Exi color camera (QImaging, 
Surrey, BC, Canada) along with Q Capture Pro imaging prgram (QImaging). Pictures 
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were taken of each sample in 4 quadrants (Northwestern, Northeastern, Southeastern, 
Southwestern) at 10x magnification and a picture of each of the steps located on the step 
ladder (1-6 including one for closed shutter and one for the black background of the 
radiograph) of each of the slides used (Figure 18). 
 
Figure 18 Sample of ladder from slide C14C15 used in density calculations, from left to right top 
to bottom ( Shutter closed, black background of radiograph = 0mm, Level 1 = 0.02mm, Level 2 = 
0.04mm, Level 3 = 0.06mm, Level 4 = 0.08mm, Level 5 = 0.1mm, and Level 6 = 0.12mm 
respectively) 
 
 The step wedge of the slides was created using increasing layers of aluminum foil 
to be used as the reference material to quantify the bone density of the samples. 
Aluminum is commonly used due to it having similar x-ray attenuation as that of cortical 
bone [38, 40]. Knowing the thickness of the aluminum we could describe the 
measurements of density as the equivalent thickness of aluminum (ETA) measured in 
millimeters. Images were taken of the bone samples and corresponding step ladders under 
the same conditions: optimal light intensity, time of day, and surrounding light sources.  
 Once the images were obtained, image analysis was performed using the software 
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Image J (Wayne Rashband (NIH)). The density and thickness of the material corresponds 
directly to the lightness and brightness of the images, whereas the brightness and 
lightness increases so does the thickness and density of the material. This can be seen in 
the example of the step wedge above (Figure 18). Each step in the step wedge 
corresponds with a known thickness. One sheet equaling 0.02mm and each step 
increasing by one sheet, ranging from 0 – 6 sheets which is equal to 0.00mm – 0.12mm 
respectively. Using Image J, histograms of the pixel intensity of the images were found. 
The pixel range was from 0-255, 0 being black and 255 being white. These histograms 
were then recorded and mean pixel intensities were determined for each level of the step 
wedge. Using the mean pixel intensities of each step of the step wedge and the known 
thicknesses of the steps the 4-parameter sigmoid curve (equation 10) could be found 
using SigmaPlot 12.3 (Systat Software, Inc.). Where Y = y-axes intercept, Yo= initial Y 
intercept, x = x-axis intercept, xo= initial x intercept, a = MAX asymptote, b = minimum 
asymptote. The 4-parameter sigmoid curve could then be used as the calibration 
parameters necessary for determining the ETA of each bone sample. 
Y = Yo + a / (1+ e
 – (x-xo / b)
)                    (Eq. 10) 
 The next step was to analyze the samples. Using Image J, a similar process was 
used to measure the brightness of the images finding the pixel intensity of the samples. 
The pixel intensity of each quadrant of a sample was found and using the calibration 
parameters the pixel intensity values could be converted to ETA. These measurements 
were performed for all samples and their corresponding step wedges. These 
measurements accounted for porosity by taking all of the counted porosity found during 
the raw data collection for each sample and dividing that number by 144, the total 
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number of possible points. This value represented the proportion of pixels that represent 
non-bone in the images, Q.  Using this value data was deleted until the remaining pixels 
equaled 1 minus Q, starting with the lowest ETA pixels.  
2.6 Statistical Analysis 
 Once the data was collected statistical analysis was performed using a 2-way 
Repeated Measures ANOVA test in SigmaPlot 12.1 (Systat Software, Inc.). This test was 
chosen to be able to measure the differences between treatment, anatomical sector, and 
calculated measurements (BV/TV, fraction of remodeled material, fraction of remodeled 
tissue, osteons per mm
2
 (material, osteons per mm
2
 (remodeled material), mean osteon 
area, CLI (bone), CLI (tissue), and CLI (remodeled material)). To make comparisons 
with the analysis, the post-hoc Fisher Least Significant Difference (LSD) test was used 
with a significance level of 0.05 used. The Least Significant Difference method is to first 
test the null hypothesis that all the population means are equal (the omnibus null 
hypothesis) with an analysis of variance. If the analysis of variance is not significant, then 
neither the omnibus null hypothesis nor any other null hypothesis about differences 
among means can be rejected. If the analysis of variance is significant, then each mean is 
compared with each other using a t-test. The results of the test were then reviewed to see 
if the sectors or treatment did have a significant difference from their comparables. A 2-
way Repeated Measures ANOVA test was also used for statistical analysis of the ETA of 
the bone samples to analyze if there was a difference seen between treatment, anatomical 
sector, and the combination of both test and sector. 
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3. Results 
3.1 Histomorphometry 
 Histomorphometric measurements were taken for Summer 3 month OVX and 
Control sheep. For each of the six sectors, the average value calculated from the four 
quadrants of the samples were found for BV/TV, the fraction of remodeled tissue, the 
fraction of the remodeled material, osteons/mm
2
 for material, osteons/mm2 for remodeled 
material, mean osteonal area, cement line interfaces of the tissue, and the cement line 
interfaces of the material, cement line interfaces of the remodeled material. The averages 
and standard deviations for each test and anatomical sectors are found in Tables I - IX. 
Table I Bone volume to tissue volume for adult 3 month summer OVX and Control ovine 
compact bone 
 
BV/TV(OVX) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.956 0.027 
Cranial 0.967 0.030 
Craniolateral 0.952 0.038 
Caudomedial 0.948 0.024 
Caudal 0.956 0.037 
Caudolateral 0.961 0.022 
BV/TV(Control) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.964 0.024 
Cranial 0.966 0.032 
Craniolateral 0.967 0.026 
Caudomedial 0.969 0.023 
Caudal 0.937 0.039 
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Table II Fraction Remodeled Tissue for adult 3 month summer OVX  and Control ovine 
compact bone 
 
Fraction Remodeled(Tissue) (OVX) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.440 0.062 
Cranial 0.434 0.062 
Craniolateral 0.489 0.069 
Caudomedial 0.461 0.081 
Caudal 0.493 0.057 
Caudolateral 0.427 0.062 
Fraction Remodeled(Tissue) (Control) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.386 0.054 
Cranial 0.416 0.055 
Craniolateral 0.461 0.070 
Caudomedial 0.477 0.071 
Caudal 0.568 0.080 
Caudolateral 0.344 0.051 
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Table III Fraction Remodeled Material for adult 3 month summer OVX and Control 
ovine compact bone 
 
Fraction Remodeled(Material) (OVX) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.461 0.062 
Cranial 0.449 0.059 
Craniolateral 0.513 0.071 
Caudomedial 0.485 0.081 
Caudal 0.516 0.058 
Caudolateral 0.444 0.059 
Fraction Remodeled(Material) (Control) 
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 0.401 0.055 
Cranial 0.431 0.053 
Craniolateral 0.477 0.072 
Caudomedial 0.493 0.071 
Caudal 0.608 0.077 
Caudolateral 0.354 0.051 
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Table IV Osteon Per mm
2
 (1/mm
2
) (Material) for adult 3 month summer OVX  and 
Control ovine compact bone 
 
Osteon Per mm
2
 (Material) (1/mm
2
)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 39.4 7.39 
Cranial 32.0 6.17 
Craniolateral 30.2 5.52 
Caudomedial 33.5 8.05 
Caudal 33.5 6.22 
Caudolateral 33.5 7.86 
Osteon Per mm
2
 (Material) (1/mm
2
)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 42.2 6.37 
Cranial 30.3 9.74 
Craniolateral 35.3 6.44 
Caudomedial 34.9 8.08 
Caudal 31.9 6.20 
Caudolateral 31.4 8.29 
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Table V Osteon Per mm
2
 (1/mm
2
) (Remodeled Material) for adult 3 month summer OVX 
and Control ovine compact bone 
 
Osteon Per mm
2
 (Remodeled Material) (1/mm
2
)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 90.2 20.7 
Cranial 73.3 16.8 
Craniolateral 61.5 11.9 
Caudomedial 74.9 29.6 
Caudal 67.2 13.2 
Caudolateral 83.4 23.5 
Osteon Per mm
2
 (Remodeled Material) (1/mm
2
)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 111 25.2 
Cranial 73.3 28.9 
Craniolateral 75.6 15.2 
Caudomedial 75.3 23.8 
Caudal 54.9 17.2 
Caudolateral 129 134 
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Table VI Mean Osteonal Area (μm2) for adult 3 month summer OVX and Control ovine 
compact bone 
 
Mean Osteonal Area (μm2)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 12100 2500 
Cranial 14500 3180 
Craniolateral 17200 3090 
Caudomedial 15600 5980 
Caudal 16100 3550 
Caudolateral 13400 3440 
Mean Osteonal Area (μm2)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 10100 3470 
Cranial 15200 4100 
Craniolateral 14000 3060 
Caudomedial 15000 4250 
Caudal 19900 4870 
Caudolateral 11700 4050 
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Table VII Cement line interfaces (Tissue) for adult 3 month summer OVX and Control 
ovine compact bone 
 
Cement Line Interfaces (Tissue) (mm/mm
2
)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 42.3 6.82 
Cranial 38.5 6.59 
Craniolateral 40.7 9.37 
Caudomedial 41.9 9.03 
Caudal 44.1 6.21 
Caudolateral 38.1 7.04 
Cement Line Interfaces (Tissue) (mm/mm
2
)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 37.7 3.92 
Cranial 36.0 6.35 
Craniolateral 42.1 7.69 
Caudomedial 44.9 8.77 
Caudal 46.8 7.03 
Caudolateral 31.2 12.9 
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Table VIII Cement line interfaces (Material) for adult 3 month summer OVX and 
Control ovine compact bone 
 
Cement Line Interfaces (Material) (mm/mm
2
)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 44.3 7.31 
Cranial 39.9 6.91 
Craniolateral 42.7 9.46 
Caudomedial 42.9 9.48 
Caudal 46.2 6.56 
Caudolateral 39.5 6.89 
Cement Line Interfaces (Material) (mm/mm
2
)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 39.2 4.50 
Cranial 37.3 6.38 
Craniolateral 43.6 8.06 
Caudomedial 46.4 8.84 
Caudal 50.0 6.80 
Caudolateral 32.1 13.2 
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Table IX Cement line interfaces (Remodeled Material) for adult 3 month summer OVX 
and Control ovine compact bone 
 
Cement Line Interfaces (Remodeled Material) (mm/mm
2
)(OVX)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 99.0 13.2 
Cranial 89.8 11.4 
Craniolateral 85.4 13.8 
Caudomedial 91.6 19.4 
Caudal 92.0 13.2 
Caudolateral 96.2 12.4 
Cement Line Interfaces (Remodeled Material) (mm/mm
2
)(Control)  
Anatomical Sector 
Group Mean Standard Deviation 
Craniomedial 101 15.4 
Cranial 87.4 9.8 
Craniolateral 92.6 16.7 
Caudomedial 95.9 12.9 
Caudal 84.2 15.4 
Caudolateral 99.6 27.8 
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3.1.1 Two Way Repeated Measures ANOVA 
 
 A 2-way repeated measures ANOVA was performed to statistically test the OVX 
sheep against the control sheep, anatomical sectors against each other, and the possible 
variance between OVX sectors and control sectors. A p-value of less than 0.05 was 
considered as showing significant difference. Table X is a summary of the p-values 
obtained from the 2-way repeated measures ANOVA for each of the calculated 
remodeling parameters in this study. 
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Table X P – values for 2-way repeated measures ANOVA of remodeling parameters 
2-way repeated measures ANOVA of remodeling parameters 
Parameter Treatment Sector Interaction of 
Treatment and 
Sector 
BV/TV 0.451 0.498 0.547 
Fraction Remodeled 
(Tissue) 
0.578 <0.001 0.114 
Fraction Remodeled 
(Material) 
0.562 <0.001 0.050 
Cement Line Interface 
(Tissue) 
0.622 <0.001 0.258 
Cement Line Interface 
(Material) 
0.588 <0.001 0.186 
Cement Line Interface 
(Remodeled Material) 
0.881 0.061 0.627 
Osteons/mm^2 
(Material) 
0.750 <0.001 0.542 
Osteons/mm^2 
(Remodeled Material) 
0.226 0.018 0.400 
Mean Osteonal Area 0.581 <0.001 0.064 
 
 There was a significant variation seen between anatomical sectors in each 
parameter other than BV/TV, Cement Line Interface (Remodeled Material), and 
Osteons/mm^2 (Remodeled Material). Parameters that showed no demonstrable 
difference were related to Remodeled Material, specifically to the Cement Line Interfaces 
and Osteons/mm^2. 
There was no significant variation found between OVX vs. control sheep seen in 
the 3 month summer sheep. There was however a significant variation when comparing 
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anatomical sectors between OVX and control sheep for Fraction Remodeled (Material) 
sector 5, Mean Osteons Area Sector 5, and Osteon Per Field (Remodeled Material) Sector 
6 (Figure 21, 22, 24). The control sheep showed a higher fraction of remodeling than the 
OVX sheep in sector 5. Control sheep showed having a larger mean osteonal area than 
OVX sheep in sector 5 (Figure 22). Sector 5 refers to the caudal region of the bone. 
Control sheep also showed an increased mean of osteons per mm
2
 (Remodeled Material) 
than OVX sheep in sector 6.  
 
 
 
Figure 19 Mean BV/TV for control and OVX sheep for each anatomical sector. 
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Figure 20 Mean Fraction Remodeled (Tissue) for control and OVX sheep for each anatomical 
sector. 
 
 
 
Figure 21 Mean Fraction Remodeled (Material) for control and OVX sheep for each anatomical 
sector. The asterisk (*) represents a significant difference. 
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Figure 22 Mean Osteon Area for control and OVX sheep for each Anatomical sector. The asterisk 
(*) represents a significant difference. 
 
 
 
Figure 23 Average number of Osteons Per mm
2
 (Material) for control and OVX sheep for each 
anatomical sector. 
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Figure 24 Average number of Osteons Per mm
2
 (Remodeled Material) for control and OVX 
sheep for each anatomical sector. The asterisk (*) represents a significant difference. 
 
 
 
Figure 25 Average Cement Line Interface of mm/mm
2
 (Tissue) for control and OVX sheep for 
each anatomical sector. 
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Figure 26 Average Cement Line Interface of mm/mm
2
 (Material) for control and OVX sheep for 
each anatomical sector. 
 
 
 
 
Figure 27 Average Cement Line Interface of mm/mm
2
 (Remodeled) for control and OVX sheep 
for each anatomical sector. 
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3.2 Densitometry 
 
 Images were taken of the bone samples and corresponding aluminum step 
wedges. The mean pixel intensity values of each step wedge were then determined.  The 
mean pixel intensity values along with the known equivalent thickness of aluminum 
(ETA) values for the step wedges were graphed and fit to a 4-parameter sigmoid curve to 
create the calibration curve for each step wedge. Using the images of the bone samples, 
mean pixel intensities were determined for each quadrant of the sample and using the 
calibration curve the ETA for each quadrant was found. Measurements were taken for 
each sector of all 3 month summer OVX sheep and all 3 month summer Control sheep. 
The mean ETA values and standard error for each anatomical sector for both OVX and 
Control sheep is shown in Table XIV. 
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Table XI Mean ETA values and Standard Error of each sector in Control and OVX sheep 
 
Average ETA's and Standard Deviations of Control and OVX Sheep 
OVX Sheep 
 Sector Average ETA Standard Deviation 
1 0.079 0.012 
2 0.076 0.016 
3 0.078 0.014 
4 0.072 0.017 
5 0.073 0.010 
6 0.071 0.013 
Control Sheep  
1 0.097 0.028 
2 0.091 0.032 
3 0.092 0.032 
4 0.093 0.032 
5 0.090 0.032 
6 0.101 0.031 
 
 A 2-way repeated measures ANOVA was performed to statistically test the OVX 
sheep against the control sheep, anatomical sectors against each other, and the possible 
variance between OVX sectors and control sectors. Table XV is a summary of p-values 
obtained from the 2-way repeated measures ANOVA for ETA. 
Table XII P – values for 2-way repeated measures ANOVA of ETA 
 
P-values from 2-way repeated measures ANOVA of ETA 
Treatment Sector Treatment and Sector 
<0.001 0.979 0.941 
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A statistical difference was seen in the density of the bone between the OVX vs 
Control sheep (Figure 28, 29). The control sheep showed a greater density in all 
anatomical sectors vs the OVX sheep. The greatest variance was seen between the 
caudolateral sectors of the two types of sheep. There was no statistical difference seen 
between sectors for both test groups. 
 
Figure 28 Average ETA of each anatomical sector of OVX vs. Control with Standard Deviation 
bars 
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Figure 29 Anatomic variability in density measured in equivalent thickness of aluminum (ETA) 
for OVX and Control Sheep. The polar graph orients the values for each sector in their 
approximate anatomical location. The radial distance is directly proportional to the value of ETA 
in mm. 
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4. Discussion 
 Osteoporosis has become a universal health issue affecting millions of people 
[41]. With increasing age bone becomes more porous and decreases in density leading to 
the bone disease known as osteoporosis. Those suffering from osteoporosis are at much 
higher risk of bone fractures, limiting their ability to care for themselves. Currently the 
initial clinical manifestations of osteoporosis are due to the incidence of low-trauma 
fractures from such things as: coughing, rolling over in bed, or even bending over to put 
on shoes [41]. Patients suffering from osteoporosis experience a severe decrease in 
quality of life and increase their dependency on aid from others as well as other device 
aids to help with movement and normal tasks [42]. With an increasing population of 
people over the age of 50 it is imperative to improve detection methods of osteoporosis to 
limit the risk of bone fracture. Some methods of detecting important factors such as one's 
bone mineral density (BMD) exist, such as DEXA. However, most patients that are 
diagnosed with osteoporosis are not diagnosed until after their first low trauma fracture 
due to inadequate detection and diagnosis of these patients prior to the incident [43]. 
Many times it is difficult to correlate a trauma event with osteoporosis because the 
fracture can occur during a low trauma event or during a moderate trauma event [43]. To 
better assess if a patient is more likely suffering from osteoporosis is to first better 
understand the risk factors that can be associated with increased risk of osteoporosis. 
Some of the most prevalent risks are gender and increased age, were women are four 
times more likely to be affected by osteoporosis than men and the increasing risk after the 
age of 50 in both men and women [41]. Some other risks associated with increased 
chances to be affected by osteoporosis are caused by smoking, excessive alcohol and 
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caffeine consumption, sedentary lifestyle, and low body weight (<127 lbs) [41]. 
 Along with understanding risk factors that lead to osteoporosis, it is also 
necessary to have sufficient osteoporosis detection methods to help assess a patient’s 
likelihood of having osteoporosis. As mentioned above one commonly used method for 
determining the BMD is the use of DEXA. However, BMD is just one factor of assessing 
bone strength. The overall strength of bone and its possible fragility are influenced by 
multiple parameters including mineralization, bone turnover rate, and trabecular and 
cortical bone microarchitecture [44]. There are other methods that can further assess the 
microarchitecture of bone. Some of the more optimal methods include computed 
tomography and magnetic resonance primarily because they can assess the bone’s 
microarchitecture in vivo. Another promising method used is high-resolution peripheral 
quantitative computed tomography, which can assess both bone density and its 
microarchitecture. Figure 30 shows that this method can allow physicians to be better 
able to assess a patient’s osteoporotic risk. 
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Figure 30 Images of the tibia(left)and radius (right). A. View demonstrating the reference line 
(solidline) and the measurement site (between dotted lines); B-E, images from a premenopausal 
(b), postmenopausal osteopenic (C), postmenopausal osteoporotic (D), and postmenopausal 
severe osteoporotic (E) subject. [45] 
 Animal models are often used to better understand diseases and possible 
treatments. For osteoporosis research it is imperative that the animal exhibit osteoporotic 
 69 
characteristics. An ovariectomy surgery, involving the removal of the ovaries, is used to 
simulate osteopenia in animals. It has shown to an effective treatment in many different 
animal models, showing osteoporotic characteristics such as increased bone turnover that 
then leads to bone loss [27]. This treatment allows for a useful model of not only 
osteoporosis, but of postmenopausal osteoporosis as well. Rat models having undergone 
ovariectomies show alteration in cancellous bone that is identical to the bone loss seen in 
humans during aging and menopause [46]. Other animal models that have shown 
reduction in cancellous bone due to ovariectomies include primates and sheep. 
 When initially testing the pathophysiology of bone loss, menopause, and the 
proposed therapy options, small animals such as rats and mice are the preferred animal 
model. Smaller animals are preferred due to having advantages over larger animal models 
in being much more cost effective. There are drawbacks to using a smaller animal model 
including differences in biomechanical bone characteristics, hormone profiles, and 
reproductive physiology causing a less accurate simulation of human osteoporosis. 
Smaller animal models also lack the size to test implantable devices interactions with 
bone tissue undergoing bone loss [47]. As mentioned above primates are another animal 
model that has obvious advantages of being a more suitable animal model due to their 
closer similarities in hormonal profiles, anatomies, and size to humans. The main 
disadvantages to utilizing primates as a plausible animal model are the difficulty of 
handling, needing older primates, and having an extremely higher cost [27]. 
 Taking into account the disadvantages to using a rat and primate model, a sheep 
animal model is a well suited option for analysis of postmenopausal osteoporosis for 
many reasons. Some of the advantages to utilizing a sheep model are that sheep show 
 70 
bone loss with estrogen depletion, have similar hormone profiles compared to human 
females, and have similar Haversian remodeling. One noticeable drawback to using sheep 
as an optimal model is the fact that some breeds are seasonally polyestrous and have 
periods of anestrus, where the animal naturally undergoes estrogen depletion [29]. This is 
the largest difference between the human model and the sheep model. However, this has 
been taken into consideration and the effects of seasonality have been studied in another 
portion of this animal study on the effects of estrogen depletion on bone remodeling. 
  Along with seasonality a few other important factors have not been assessed in 
using a sheep model for the study of post-menopausal osteoporosis. These include 
findings of possible variation due to anatomical sector in bone and effective amount of 
time post ovariectomy to begin to show statistical changes in resorption surfaces, 
osteoblast surfaces, bone formation rates, and bone mass. Previous studies have used 
sheep as a better model of osteoporosis using the parameters mentioned above, but 
measured over a period of 18 months [31]. This however does not account for possible 
changes in earlier remodeling cycles as well as for anatomical sectors of bone. It is 
known that the resorption and remodeling process takes roughly 3 months to complete 
[7]. So it is reasonable to believe some noticeable changes may occur after one 
remodeling cycle post ovariectomy. One study has shown that 3 months after 
ovariectomy surgery there was a statistical difference seen in resorption surface, 
osteoblast surface and bone formation values, but a change in BMD was not seen until 
6months [34]. This study also did not account for any variation due to anatomical region 
in the cross section of the bone.  
 There are a number of reasons why taking into account the possible variation due 
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to anatomical region would be useful in the study of the effects of osteoporosis on bone 
remodeling. Bone undergoes a multitude of stresses during activity. In particular the 
caudal cortex of bone in the leg is in compression and the cranial cortex is in tension with 
lower stresses in the lateral and medial sections of bone [48]. With different anatomical 
regions of bone undergoing different types of strains it would be a reasonable suggestion 
to study the effects of osteoporosis on different anatomical regions of bone. One study 
has shown that there was in fact, a statistically significant variation in bone 
mineralization between anatomical regions of a cross section of bone [49]. 
 In this study we looked to see if there were noticeable changes to the bone after 
one remodeling cycle, there was a significant effect on data in this study due to 
anatomical sector. Analysis of the OVX and control data on 3 month summer sheep 
showed variation at the caudal sector 5 location for fraction remodeled material and the 
mean osteon area. The significant variation seen was expected due to the different load 
types experienced by each sector. The control sheep showed a significantly higher 
fraction of remodeled material than that of the OVX sheep. In order for this to happen, 
the OVX sheep would need to be modeling bone, which would show up as unremodeled 
bone or that the OVX sheep had a lower amount of remodeled bone at the time of surgery 
than that of the control sheep. The significant variation seen in the mean area of osteons 
in sector 5 supports this assumption that the control sheep had a greater amount of 
remodeled tissue. The control sheep had significantly larger Osteons as compared to that 
of the OVX sheep. This could possibly be due to the expected post-OVX remodeling 
burst creating smaller osteons. It is understandable to see the most variation in sector 5, 
as it is the most active region of the bone, the caudal region corresponds to an area of 
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high compression [50]. The samples used were taken from a 1.5mm x 1.5mm beam in 
sector 5. It may be considered that due to the high variation in bone properties in this 
region of the bone, the sample size taken from sector 5 may be too small to get a varied 
enough sample size of bone to come to any definitive conclusions.  A significant variation 
was also seen in the average osteons per mm
2
 of the remodeled material in sector 6. The 
control sheep showed a higher average of osteons per mm
2
 than the OVX sheep, the 
control sheep also had a significantly larger Standard Deviation than OVX. This can be 
attributed to the fact that the ulna is adjacent to sector 6 and could have been in a fusing 
process with the radius in some of the control sheep causing the increased variability 
seen. It should also be noted that the mean osteonal area found was about half what you 
would expect with osteons having an average diameter of 200 µm. This could be due to 
the fact that calculation used osteons per mm
2
, however, many osteons overlap causing 
the calculated mean area to be less than expected. Significant variations in the other 
parameters tested during this study were not seen between the control and OVX sheep as 
well as between the anatomical sectors of bone. This was expected, because of the 
minimal remodeling that could occur within 3 months of the ovariectomy surgery.  
 Significant variation in the equivalent thickness of aluminum (ETA) was seen 
between the control and OVX sheep at the 3 month time point. A time period of 3 months 
has shown to be a long enough period post ovariectomy to see significant change in the 
density of the bone. This shows that there could be a substantial increase in the resorption 
of bone as compared to pre-ovariectomy bone due to estrogen depletion and the increase 
in osteoclastogenesis. There was no significant variation seen between sectors and was 
seen as an overall decrease in ETA between OVX sheep and control sheep. 
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 There were a few limitations to this study including the purchase cohort effect. 
This is relevant to the study because the sheep that where purchased were already 
skeletally mature as a result of previous remodeling cycles experienced before their 
arrival at Colorado State University. This effect was minimized by maintaining a 
uniformity of where the sheep were housed and by giving them the same feed and 
exercise conditions during their post-operative time. Time in these conditions was also 
taken into account and was most optimal for the 12 month sheep and understandably 
restrained for the 3 month sheep. 
  Another constraint that was found during this study was the projection of the 3D 
structure of the bone samples onto a 2D plane, as seen in the microradiographs. With the 
projection of the 3D structure onto a 2D plane, the density of the sample may interfere 
with the dimensions of the features being measured on the microradiographs. This poses 
a problem when making histomorphometric measurements from the microradiographs 
without optimal accuracy, however with the samples being of 100 microns in size this 
should be minimal at the most.  Along with the issues of projecting a 3D feature onto a 
2D plane, there were a few issues with obtaining optimal exposure on the 
microradiographs. The issues with exposure caused low visibility on a number of the 
specimens creating difficulty in obtaining the most accurate histomorphometric 
measurements. The exposure issues also played a role in the densitometry measurements. 
The main issue being that some sectors would be over exposed (too bright) or that some 
would be under exposed (to dark). This was partially resolved by changing the lighting 
during image retrieval to optimize visualization of the images to be used in creating the 
sigmoidal curves. 
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 With the results found from this study, there can potentially be many more studies 
done to further increase the understanding of the effects of estrogen depletion on bone 
remodeling. One such area that is of interest is to study if the effects of seasonality have 
any effect on 3 month ovariectomized sheep. Also we can further study the effects of 
estrogen and other drug therapies on osteoporotic bone using an OVX sheep model that 
takes into account seasonality and anatomical sector of bone. This would aid in better 
understanding where these treatments affect such parameters as BMD, resorption 
surfaces, osteoblast surfaces, and bone formation rates as compared to non-treated OVX 
sheep. 
 With the OVX data collected it is apparent that there were significant variations in 
parameters in bone remodeling seen in specific sectors even 3 months post-surgery. It 
was also seen that there was a significant difference in bone density at this same time 
point. With this knowledge we can see that different anatomical regions are not affected 
by bone loss equivalently, but rather increased based on the amount of stress associated 
with that region. As a result, it is important for protocols of future studies to take into 
account, not only the treatments but also the anatomical regions and time period of 
analysis. This research has shown that there are many different levels of remodeling seen 
in the adult OVX ovine model, shows that this is a useful model for post-menopausal 
osteoporosis for 3 month OVX sheep, and that an ovariectomy does have significant 
effect on bone remodeling for a 3 month post-op ovine model. 
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5. Conclusion 
 The use of an ovariectomized adult ewe can provide an economical large animal 
model for studies of postmenopausal osteoporosis and compact bone remodeling. Using a 
sheep as the animal model offers many advantages over other possible animal models. 
Sheep have shown that they exhibit similar Haversian remodeling to humans due to 
similar hormonal, exercise, and dietary changes. Along with showing similar bone 
remodeling they offer a large animal model that implant devices can be tested as 
treatment methods. With ovariectomized sheep showing similar effects on remodeling as 
seen during menopause in human women, it makes it an ideal model for postmenopausal 
osteoporosis studies. 
 The sheep model used in this portion of the research involved the use of 2 groups 
of sheep, ovariectomized sheep and control sham surgery sheep, which both underwent 
surgery in the summer and were sacrificed at 3 months post-surgery. The procedures and 
handling of the sheep took place at Colorado State University where after sacrifice the 
sheep's right and left radius and ulna bone were removed and sent to Henry Ford Hospital 
for further preparation and analysis. Once at the Henry Ford Hospital the left radius and 
ulna bone were used for mechanical testing. The right radius and ulna bone were cut into 
a cross section then divided into six anatomical sectors and ground down to a final 
thickness of 100m for microradiograph imaging. Along with the bone samples an 
aluminum step wedge was created and imaged with the bone samples to provide a key for 
the densitometry analysis to be performed. Once the microradiograph slides were 
completed, they were sent to California Polytechnic State University, San Luis Obispo for 
histomorphometric and densitometry analysis. 
 76 
 For the histomophometric analysis portion of this study, the microradiographs of 
the bone samples taken from the aforementioned sheep were viewed under a white light 
microscope with overlaying Merz grid. Using the Merz grid the anatomical bone sectors 
were divided into quadrants for taking measurements. The following measurements were 
taken to quantify bone remodeling: porosity, remodeled bone, number of secondary 
osteons, and cement line interfaces. The values taken from each quadrant were averaged 
for each sector of bone. Using these values, bone remodeling parameters were calculated 
using a Microsoft Excel spreadsheet. The parameters found were the bone volume to 
tissue volume ratio (BV/TV), fraction remodeled tissue and bone, the cement line 
interfaces of tissue and bone, osteons per mm
2
, and the mean osteon area. 
The densitometry portion of this study required computational images taken of 
each specimen along with its corresponding aluminum step wedge on the 
microradiographs. When taking these images, light intensity and exposure rates were kept 
constant for each specimen and their corresponding step wedge to reduce possible error 
from variation. These images where then processed using digital image analysis software 
to measure the light intensity of each pixel on a scale of 0 to 255. This was performed for 
each sector and each step of the step wedge. Using the mean pixel intensity of each step 
of the step wedges a key could be determined for a calibration curve. Using the calculated 
calibration curve found from the step wedges, the mean pixel intensities of the bone 
specimens could be used to calculate their equivalent thickness of aluminum (ETA) 
giving us a quantitative value for density of each specimen. 
 Once all data was collected for the histomorphometry and densitometry of the 3 
month OVX and control sheep statistical analysis was then performed. To best analyze 
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the data a 2-way Repeated Measures ANOVA test was ran for each remodeling parameter 
and for the ETA's. The ANOVA model performed allowed for the comparison in the 
difference seen in treatment (OVX vs. control), sector (anatomical sectors 1-6), and the 
combination of sectors and test. The histomorphic data showed a significant variation in 
sector 5 between OVX and control sheep for the fraction of remodeled material and bone 
where the control sheep in sector 5 showed a significantly higher fraction of remodeled 
material and bone than that of the OVX sheep in sector 5. A significant variation was also 
seen in sector 6 between OVX and control sheep for the average osteon per field, where 
the control sheep showed a significantly higher amount of osteons per mm
2
 than that of 
the OVX sheep. There were no significant differences seen in any of the other parameters 
between treatments for sectors. For the densitometry statistical analysis there was a 
significant difference seen between test specimens where the OVX sheep had 
significantly lower ETA's than that of the control sheep. There were no significant 
differences seen between individual sectors.  
 The significant variations in cortical bone remodeling seen at only 3 months post 
ovariectomy show that it is important to take into account the possible variations seen in 
the early stages of bone remodeling and the significant variance seen between anatomical 
sectors using sheep as the animal model, in particular the variation seen in sector 5. It is 
essential that the findings found in this study be taken into consideration when 
developing protocols for future research using the ovariectomized adult ewe as a model 
for post-menopausal osteoporosis and its possible treatments. For future research it 
should be considered to increase the sample size used. If unable to increase the number of 
animals used in the study it may be beneficial to take multiple samples from regions with 
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the most variation to increase your sample size This study shows that an ovariectomized 
sheep model can be a very useful model of postmenopausal osteoporosis and that 
variations caused by follow up times and anatomical sectors must be taken into account 
to get an even clearer interpretation of results found in future studies. 
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Appendix A : 3 Month Summer OVX Histomorphometry Data 
 
3 Month Summer OVX 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.938 0.944 0.951 0.840 0.972 0.935 
C09 0.944 0.986 0.986 0.958 0.972 0.972 
C12 0.926 0.958 0.972 0.938 0.944 0.972 
C14 0.972 0.965 0.917 0.979 0.958 0.979 
C19 0.954 0.979 0.944 0.972 0.944 0.986 
C20 0.965 0.963 0.938 0.938 0.951 0.951 
C21 0.965 0.944 0.993 0.979 0.903   
C25 0.986 0.993 0.917 0.979 1.000 0.944 
Average Fraction Remodeled (Tissue) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.542 0.382 0.618 0.424 0.444 0.509 
C09 0.479 0.438 0.417 0.285 0.491 0.347 
C12 0.454 0.431 0.521 0.500 0.382 0.424 
C14 0.431 0.514 0.417 0.438 0.438 0.319 
C19 0.454 0.521 0.563 0.590 0.569 0.535 
C20 0.368 0.361 0.549 0.396 0.500 0.375 
C21 0.486 0.410 0.563 0.611 0.597   
C25 0.306 0.417 0.269 0.444 0.521 0.361 
Average Fraction Remodeled (Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.577 0.404 0.649 0.502 0.457 0.545 
C09 0.508 0.442 0.421 0.297 0.505 0.354 
C12 0.488 0.449 0.536 0.528 0.404 0.437 
C14 0.443 0.534 0.454 0.447 0.456 0.326 
C19 0.475 0.531 0.595 0.608 0.604 0.542 
C20 0.382 0.375 0.586 0.422 0.526 0.393 
C21 0.504 0.435 0.567 0.625 0.657   
C25 0.311 0.420 0.295 0.455 0.521 0.381 
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Average Cement Line Interface (Tissue) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 48.11 31.68 45.94 36.43 38.02 35.38 
C09 38.61 40.00 40.00 32.67 51.74 32.87 
C12 40.92 40.19 49.10 39.80 40.39 41.58 
C14 48.31 53.06 43.16 51.88 41.58 34.06 
C19 42.24 35.44 47.12 58.81 55.04 52.47 
C20 44.35 34.32 38.41 36.04 45.94 37.42 
C21 47.72 38.61 42.77 43.36 39.60   
C25 27.92 34.85 19.27 36.43 40.79 32.87 
Average  Cement Line Interface (Material) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 51.24 33.59 48.28 33.53 39.15 37.81 
C09 40.95 40.53 40.51 34.02 53.22 33.56 
C12 44.09 41.88 50.44 42.37 42.77 42.77 
C14 49.72 55.17 46.91 52.93 43.58 34.83 
C19 44.44 36.13 49.97 60.46 58.22 53.38 
C20 46.11 35.60 41.23 38.56 48.26 39.34 
C21 49.48 40.94 43.10 44.34 43.92   
C25 28.34 35.11 21.32 37.18 40.79 34.87 
Average Cement Line Interface (Remodeled Material) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 90.67 83.78 75.12 67.70 88.97 70.46 
C09 80.68 95.49 101.74 116.21 106.19 95.25 
C12 93.37 93.66 94.15 82.17 105.35 100.84 
C14 114.04 103.22 106.60 119.44 96.27 107.95 
C19 95.04 66.49 85.33 101.34 96.87 99.92 
C20 122.22 95.81 72.51 91.92 96.11 105.14 
C21 99.12 95.60 76.16 70.90 67.45   
C25 96.48 84.48 71.60 83.44 78.70 93.74 
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Osteons/mm² (Tissue) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 43.25 30.25 26.50 27.25 31.33 35.00 
C09 29.50 44.50 32.75 33.25 41.00 32.75 
C12 35.00 32.50 32.25 27.00 27.75 27.50 
C14 44.25 29.00 27.25 38.25 28.50 29.75 
C19 48.33 30.00 31.50 33.75 39.50 39.00 
C20 29.50 31.33 33.50 46.00 35.50 42.00 
C21 37.00 26.25 30.75 23.50 27.00   
C25 34.25 23.50 16.33 25.00 25.25 19.50 
Osteons/mm² (Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 46.06 32.04 27.88 32.48 32.23 37.44 
C09 31.26 45.05 33.20 34.68 42.17 33.59 
C12 37.72 33.89 33.13 28.69 29.38 28.28 
C14 45.53 30.17 29.59 39.06 29.73 30.41 
C19 50.83 30.61 33.42 34.74 41.72 39.68 
C20 30.63 32.54 35.69 49.05 37.31 44.24 
C21 38.31 27.79 30.99 23.97 30.09   
C25 34.70 23.66 17.99 25.54 25.25 20.68 
Osteons/mm² (Remodeled Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 81.63 80.82 43.07 66.17 75.00 69.68 
C09 62.13 103.24 84.73 118.34 84.99 99.34 
C12 79.63 75.73 61.91 55.27 72.01 67.45 
C14 104.18 56.60 67.03 88.28 65.62 93.93 
C19 109.50 58.63 56.53 57.99 69.60 74.18 
C20 81.00 88.14 63.36 116.43 74.58 123.94 
C21 78.38 65.62 54.73 38.58 46.44   
C25 125.14 57.80 60.80 57.86 48.94 55.53 
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Mean Osteon Area (microns²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 12525.46 12734.89 23505.89 15710.55 14702.51 14581.39 
C09 16394.98 9747.72 12649.81 8738.49 11950.40 10396.34 
C12 13149.49 13254.08 16292.58 18469.26 14107.48 16199.57 
C14 9740.09 17802.82 15580.48 11555.42 15401.52 10796.80 
C19 9423.87 17169.52 17967.57 17601.17 14646.46 14087.89 
C20 12408.40 11453.66 16713.66 8605.96 14502.17 9103.65 
C21 13645.78 15636.02 18500.98 26594.26 22119.34   
C25 9112.29 18375.28 16486.63 17870.37 20956.48 18603.80 
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Appendix B: 3 Month Summer Control Histomorphometry Data 
3 Month Summer Control 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.958 0.986 0.981 0.986 0.958 0.993 
C16 0.965 0.972 0.951 0.958 0.924 0.965 
C17 0.944 0.951 0.944 0.979 0.958 0.986 
C23 0.944 0.954 0.979 0.986 0.986 0.951 
C24 0.972 0.979 0.958 0.986 0.764 0.965 
C27 0.986 0.965 0.993 0.958 0.958 0.944 
C28 0.965 0.958 0.951 0.944 0.958 0.972 
C29 0.972 0.958 0.979 0.951 0.986 0.979 
Average Fraction Remodeled (Tissue) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.347 0.389 0.426 0.514 0.438 0.410 
C16 0.347 0.444 0.403 0.625 0.611 0.521 
C17 0.354 0.500 0.424 0.458 0.708 0.375 
C23 0.542 0.370 0.493 0.549 0.576 0.347 
C24 0.410 0.493 0.486 0.417 0.507 0.486 
C27 0.396 0.333 0.444 0.410 0.535 0.167 
C28 0.319 0.431 0.479 0.389 0.590 0.083 
C29 0.375 0.368 0.535 0.458 0.576 0.361 
Average Fraction Remodeled (Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.362 0.393 0.434 0.521 0.456 0.412 
C16 0.359 0.457 0.422 0.652 0.660 0.539 
C17 0.375 0.527 0.448 0.468 0.739 0.381 
C23 0.573 0.389 0.505 0.557 0.584 0.365 
C24 0.421 0.503 0.510 0.423 0.666 0.504 
C27 0.402 0.345 0.447 0.428 0.558 0.177 
C28 0.332 0.448 0.503 0.412 0.613 0.086 
C29 0.385 0.384 0.546 0.481 0.584 0.369 
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Average Cement Line Interface (Tissue) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 31.68 40.00 48.31 46.93 48.91 35.84 
C16 37.62 36.83 39.80 60.19 44.55 40.19 
C17 40.00 41.98 40.79 54.85 60.19 37.82 
C23 44.15 25.87 41.38 43.76 38.61 29.70 
C24 34.85 43.76 44.35 43.16 38.81 48.31 
C27 34.45 29.70 25.34 37.42 51.68 13.07 
C28 39.60 38.61 46.33 35.84 45.74 11.48 
C29 39.20 31.48 50.09 37.22 45.54 33.46 
Average  Cement Line Interface (Material) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 32.99 40.50 49.30 47.62 51.20 36.07 
C16 39.03 38.07 42.12 62.74 47.99 41.53 
C17 42.50 44.05 43.26 56.02 62.75 38.37 
C23 46.83 27.21 42.26 44.37 39.17 31.08 
C24 35.84 44.58 46.21 43.72 51.23 50.06 
C27 34.94 30.55 25.44 39.14 53.94 13.66 
C28 41.09 40.17 48.68 37.97 47.50 11.81 
C29 40.25 32.87 51.10 39.24 46.18 34.16 
Average Cement Line Interface (Remodeled Material) (mm/mm²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 93.72 105.02 113.26 91.78 113.75 88.87 
C16 110.74 86.99 102.28 96.21 72.50 76.93 
C17 114.10 84.36 96.67 120.14 85.14 100.93 
C23 82.74 69.21 85.35 80.32 68.34 87.10 
C24 85.37 88.43 96.60 108.28 76.26 104.59 
C27 89.03 89.39 56.28 91.93 100.36 78.41 
C28 125.45 89.93 97.08 95.08 78.08 163.94 
C29 106.40 85.69 93.10 83.66 79.14 95.87 
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Osteons/mm² (Tissue) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 35.75 51.75 36.33 27.75 39.50 34.00 
C16 43.50 24.50 30.75 37.75 34.50 37.00 
C17 44.25 24.25 41.25 48.00 32.50 32.25 
C23 32.75 23.67 35.50 25.00 23.00 29.00 
C24 46.75 35.00 39.50 41.50 19.75 40.50 
C27 33.00 28.25 23.00 27.50 33.50 16.00 
C28 40.50 24.00 35.75 29.75 30.75 33.50 
C29 48.75 23.25 30.50 33.25 26.25 21.75 
Osteons/mm² (Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 37.25 52.49 37.04 28.14 41.34 34.23 
C16 45.02 25.22 32.34 39.45 37.25 38.28 
C17 46.89 25.55 43.72 49.01 33.88 32.69 
C23 34.72 24.83 36.29 25.32 23.31 30.51 
C24 48.09 35.72 41.27 42.01 25.82 41.95 
C27 33.51 29.25 23.15 28.74 34.94 16.63 
C28 41.98 25.05 37.63 31.52 32.07 34.46 
C29 50.17 24.30 31.10 35.08 26.64 22.22 
Osteons/mm² (Remodeled Material) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 107.19 139.24 85.20 54.28 91.27 83.91 
C16 128.88 56.09 78.15 60.73 56.35 70.86 
C17 125.44 48.50 98.76 105.13 45.97 86.35 
C23 62.40 65.96 73.78 45.99 40.37 84.73 
C24 114.67 71.14 84.87 113.68 39.09 87.06 
C27 83.65 85.65 52.63 67.94 66.00 96.00 
C28 129.00 56.09 75.27 79.79 53.82 459.00 
C29 132.53 63.40 56.49 74.57 45.96 61.94 
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Mean Osteon Area (microns²) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 10096.70 7536.85 11756.92 18526.15 11102.17 12010.63 
C16 7930.87 18018.43 13055.20 16788.70 18041.64 14171.12 
C17 8035.21 20637.51 10274.97 9587.04 21957.67 11684.37 
C23 17890.80 15616.03 13944.93 22300.82 24979.11 12098.16 
C24 9006.84 14129.85 12311.62 10155.54 25752.31 12121.21 
C27 12047.37 11794.50 19261.23 14982.99 16150.03 12121.21 
C28 8092.71 17981.24 13629.85 12957.76 19064.72 2529.76 
C29 7715.07 16047.98 17860.58 14282.46 22405.60 16609.55 
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Appendix C: 3 Month Summer OVX Densitometry Data 
3 Month Summer OVX 
Average ETA 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.0772 0.0749 0.064 0.0399 0.06 0.0696 
C09 0.1042 0.0949 0.0996 0.0678 0.0795 0.0426 
C12 0.0844 0.0457 0.0766 0.0622 0.0696 0.0743 
C14 0.0814 0.0614 0.0651 0.0618 0.0633 0.0723 
C19 0.0615 0.0715 0.0783 0.0859 0.0851 0.0715 
C20 0.0765 0.0909 0.0915 0.083 0.0789 0.0817 
C21 0.0788 0.0861 0.0878 0.0861 0.0812   
C25 0.0693 0.0833 0.0643 0.0814 0.065 0.0911 
Standard Deviation 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.01076 0.009479 0.011819 0.0204077 0.020445 0.012876 
C09 0.00705 0.007183 0.006794 0.013441 0.009934 0.01506 
C12 0.006274 0.013284 0.010155 0.013918 0.009165 0.008771 
C14 0.00847 0.007326 0.008933 0.009943 0.022878 0.012552 
C19 0.007803 0.007272 0.007206 0.006685 0.007764 0.01182 
C20 0.010872 0.007462 0.009074 0.007358 0.011203 0.00807 
C21 0.011196 0.006654 0.009375 0.008391 0.004868   
C25 0.00302 0.007047 0.006177 0.013282 0.007864 0.003053 
Range 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C02 0.065359 0.062046 0.057868 0.134553 0.103256 0.08122 
C09 0.043222 0.051311 0.054571 0.06355 0.059979 0.069461 
C12 0.039973 0.058002 0.05441 0.069214 0.042117 0.055821 
C14 0.047125 0.047008 0.052387 0.062442 0.108177 0.078249 
C19 0.0367 0.053736 0.043431 0.042139 0.042139 0.066198 
C20 0.061507 0.057689 0.06756 0.038493 0.058777 0.045065 
C21 0.054399 0.056728 0.068674 0.054843 0.044979   
C25 0.02099 0.079082 0.030558 0.091878 0.096042 0.042572 
 
 91 
Appendix D: 3 Month Summer Control Densitometry Data 
3 Month Summer Control 
Average ETA 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.1031 0.0956 0.0955 0.1023 0.1019 0.1023 
C16 0.0799 0.0711 0.081 0.0722 0.0609 0.0891 
C17 0.1607 0.1654 0.1657 0.1621 0.1602 0.172 
C23 0.0867 0.0779 0.0963 0.08 0.0946 0.0788 
C24 0.0869 0.0673 0.0713 0.094 0.0819 0.0692 
C27 0.0758 0.0722 0.0828 0.0898 0.0791 0.0939 
C28 0.0794 0.0787 0.0603 0.0501 0.0578 0.0995 
C29 0.1037 0.097 0.079 0.0956 0.0831 0.1012 
Standard Deviation 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.008988 0.008385 0.007427 0.009303 0.008618 0.009174 
C16 0.009069 0.007501 0.006885 0.008186 0.00783 0.009348 
C17 0.014854 0.009085 0.0086 0.011278 0.009348 0.010003 
C23 0.007654 0.008737 0.008679 0.009655 0.005927 0.010541 
C24 0.010368 0.007763 0.014368 0.00939 0.008186 0.015985 
C27 0.010124 0.008157 0.007182 0.006966 0.007768 0.00379 
C28 0.008363 0.008457 0.007933 0.010091 0.009308 0.004901 
C29 0.007669 0.008603 0.006943 0.00882 0.006606 0.0059 
Range 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C15 0.407696 0.05338 0.045168 0.053155 0.04272 0.055174 
C16 0.049275 0.056532 0.039861 0.045023 0.053456 0.055416 
C17 0.069684 0.059311 0.044136 0.059439 0.051827 0.069684 
C23 0.052901 0.048221 0.050423 0.054988 0.051483 0.056294 
C24 0.05121 0.052278 0.074265 0.055475 0.074873 0.082031 
C27 0.054527 0.04248 0.063926 0.057717 0.066968 0.042768 
C28 0.04383 0.059633 0.048148 0.049122 0.0603067 0.037311 
C29 0.049121 0.045595 0.047983 0.049053 0.056394 0.044323 
 
